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ABSTRACT 
Primary open-angle glaucoma (POAG) is a leading cause of blindness in the 
world. A primary risk factor for POAG is elevated intraocular pressure (IOP), caused by 
increased aqueous humor outflow resistance. Currently, lowering the IOP is the only 
effective way of treating glaucoma; however, the cause of increased outflow resistance 
remains unclear. This thesis will present a series of studies which investigated structures 
of the trabecular outflow pathway, including Schlemm’s canal endothelium, 
juxtacanalicular tissue, and trabecular beams, and their roles in regulating aqueous 
outflow resistance. The studies were conducted in both human and animal models using 
ex vivo ocular perfusion as well as in vitro microfluidic systems. In the first study, we 
investigated the effects of Y27632, a derivative of Rho-kinase inhibitor that is being 
developed as next generation glaucoma drug with unclear IOP lowering mechanism, on 
aqueous humor outflow dynamics and associated morphological changes in normal 
vii	
human eyes and laser-induced ocular hypertensive monkey eyes. In the second study, we 
developed and validated a novel three-dimensional microfluidic system using lymphatic 
microvascular endothelial cells. The microfluidic system can be used to study Schlemm’s 
canal endothelial cell dynamics and aqueous humor transport mechanism in the future. In 
the last study, we characterized the morphological structure, distribution, and thickness of 
the endothelial glycocalyx in the aqueous humor outflow pathway of human and bovine 
eyes. Together these studies will help define new directions for therapy that will help 
control IOP and preserve vision throughout a normal life span. 
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CHAPTER 1 – GENERAL INTRODUCTION 
 
Primary open angle glaucoma 
 
Primary open angle glaucoma (POAG) is a leading cause of irreversible blindness 
worldwide, with more than 44.1 million individuals over forty-years of age having POAG 
in the world in 2013, increasing to 52.7 million in 2020 and 79.8 million in 2040 (Tham 
et al. 2014). POAG is usually associated with high intraocular pressure (IOP) which 
damages ganglion cell axons at the optic nerve head leading to vision loss (Gordon et al. 
2002, Leske et al. 2003). Lowering the IOP is the only proven treatment to prevent 
development of POAG or worsening of visual loss (Maier et al. 2005). Therefore, 
understanding how IOP is generated and regulated, and why it is elevated in POAG is 
imperative to understand the disease mechanism. 
 
Aqueous humor outflow pathway 
To understand how IOP is generated, we have to first understand aqueous humor 
dynamics. Aqueous humor is a clear fluid that fills the anterior and posterior chambers of 
the eye and provides nutrients to avascular structures, including lens and cornea. Aqueous 
humor is continuously secreted by the epithelium cells of the ciliary body and flows from 
the posterior chamber through the pupil into the anterior chamber. From there aqueous 
humor leaves the eye through two pathways at the iridocorneal angle: the trabecular 
(conventional) outflow pathway and the uveoscleral (unconventional) outflow pathway. 
In the trabecular outflow pathway, aqueous humor flows first through the trabecular 
meshwork (uveal meshwork, corneoscleral meshwork and juxtacanalicular tissue [JCT]), 
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crosses the inner wall endothelium of Schlemm’s canal (SC), into the SC lumen, and then 
drains into collector channels, aqueous veins, and episcleral veins (Goel et al. 2010). In 
the uveoscleral outflow pathway, aqueous humor flows into the connective tissue 
between ciliary muscles, through the suprachoroidal space, and exits through the sclera 
(Figure 1.1).  
Within the normal range of IOP, flow through the trabecular outflow pathway is 
considered pressure-dependent (Tamm 2009) while uveoscleral outflow is referred to as 
pressure-independent (Alm and Nilsson 2009). Trabecular outflow increases with higher 
IOP; uveoscleral outflow is a passive diffusion process with a constant flow independent 
of fluctuation in IOP. Utilizing this physiological phenomenon allows us to measure the 
aqueous humor dynamics and establish the relationship between the IOP, episceral 
venous pressure (Pev), aqueous flow (Fin), uveoscleral flow (Fus), and outflow facility (C) 
through the trabecular outflow pathway as described by the Goldmann equation: IOP = 
Pev + (Fin - Fus) / C. However, there are several obstacles to assess the accurate value for 
each variable (Goel et al. 2010). First, non-invasive measurement of uveoscleral flow in 
human is impossible because of the injection of tracers into the anterior chamber. The 
values of uveoscleral flow have been obtained from experiments conducted primarily in 
monkey eyes (Bill 1965). Second, the episceral venous pressure is often assumed because 
of imprecise measurement methods (Gaasterland and Pederson 1983). Recently, a novel 
non-invasive episceral venous pressure measurement was shown with improved accuracy 
and objectivity; however, parameter estimation is still required (Sit et al. 2011). Third, 
while IOP is an instant measurement, aqueous outflow is the average of over several 
3	
hours of measurement. Thus, uveoscleral outflow measurement can be varied differently 
depending on several factors (Johnson, McLaren, and Overby 2016). Nevertheless, 
uveoscleral outflow pathway is believed to contribute between 12-46% of total aqueous 
outflow while the rest is through the trabecular outflow pathway (Toris, Camras, and 
Yablonski 1993, Toris et al. 1999, Toris et al. 2002, Johnson et al. 2008), making 
trabecular outflow pathway the major outflow aqueous outflow pathway.  
 
Aqueous outflow resistance 
In normal healthy eyes, IOP stays relatively constant because equilibrium exists 
between the production and drainage of the aqueous humor. However, in the POAG eyes, 
IOP is elevated due to dysfunctions in the drainage pathways, manifested by an increase 
in aqueous outflow resistance. Although the mechanism behind increased outflow 
resistance in POAG remains unclear (Johnson 2006, Tamm and Fuchshofer 2007), 
current research suggests that an increase in outflow resistance of the trabecular outflow 
pathway is the main culprit (Johnson 2006, Tamm and Fuchshofer 2007). Indirectly, 
studies supporting this conclusion have showed that uveoscleral outflow is reduced with 
increasing age (Toris et al. 1999) as the result of reduced spaces between the ciliary 
muscle bundles (Tamm, Tamm, and Rohen 1992). Thus, a further reduction in 
uveoscleral flow as the result of uveoscleral pathway dysfunction in glaucoma is likely to 
only have a modest effect on IOP. The aqueous humor resistance through the trabecular 
outflow pathway is known to increase with age; however, in the normal aging process, 
the IOP is not affected because aqueous humor secretion decreases in parallel with 
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increasing age (Brubaker et al. 1981, BECKER 1958, Toris et al. 1999, Gabelt et al. 
2003). Even so, the outflow resistance in the trabecular outflow pathway of POAG eyes 
is higher than in age-matched normal control eyes (Johnson 2006) while aqueous humor 
secretion is unchanged (Brubaker 1991, Larsson et al. 1993). Thus, understanding what 
controls the aqueous outflow resistance in the trabecular outflow pathway is an important 
first step to understand the increase in IOP in POAG eyes.  
 
Structure of the trabecular outflow pathway  
The regions of outflow resistance in the trabecular outflow pathway are separated 
by SC into tissues that are upstream of SC and downstream of SC. Following complete 
trabeculotomy, the surgical procedures that removes TM (upstream of SC), between 50-
75% of outflow resistance was eliminated (GRANT 1958, Ellingsen and Grant 1972, 
Rosenquist et al. 1989). The results indicated that although the distal aspect of the 
trabecular outflow pathway, namely the collector channels, scleral venous plexus and/or 
aqueous veins, contributed a significant amount of the outflow resistance, the majority of 
the outflow resistance resides in the region in the upstream of SC. More importantly, the 
region upstream of SC is likely the site where the changes occurred in POAG eyes 
(Stamer et al. 2014). Further support for this conclusion can be found in the success of 
trabeculotomy and laser trabeculoplasty, which eliminate majority if not all of the 
elevated outflow resistance in POAG eyes (Wise and Witter 1979, Spencer 1972, 
Schwartz and Anderson 1974).  
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To this date, it is still not completely understood which tissue structures upstream 
of SC play major roles in regulating outflow resistance in normal eyes and contributing to 
an increase in outflow resistance in POAG eyes. It is generally considered that most, if 
not all of the upstream outflow resistance is generated by only the inner wall region of the 
SC, consisting of the inner wall endothelial cells of SC, the SC endothelial cells basement 
membrane, and the adjacent juxtacanalicular tissue (JCT) (Overby, Stamer, and Johnson 
2009, Gong and Freddo 2009, Tamm 2009) (Figure 1.2). 
 
Trabecular beams 
Trabecular beams, residing in the most proximal region of the TM, are part of the 
corneoscleral and uveal trabecular meshwork. They contain densely packed collagen type 
I and III (Marshall, Konstas, and Lee 1991), and elastic fibers with electron-dense 
materials that localize to the core of the beams (Gong, Trinkaus-Randall, and Freddo 
1989, Lütjen-Drecoll et al. 1989). Additionally, there is long-spacing collagen and fine 
fibrils found between the elastic fiber core and the basal lamina of the TM cells. TM cells 
are endothelial cells that cover the trabecular beams. Trabecular beams are often 
considered of little importance in contributing to the outflow resistance due to their 
highly porous meshwork with opening size range from 2-15 μm for the corneoscleral 
meshwork and 25-75 μm for the uveal meshwork (Tripathi 1974). Given the rate of 
aqueous humor outflow at 2.4 μL/min (Brubaker 1985). Poiseuille’s law showed these 
two regions of the TM contribute to negligible flow resistance (McEWEN 1958). Further 
experimental study supported this conclusion and showed that cutting the trabecular 
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beams had no effect on outflow resistance (Grant 1963). On the other hand, some TM 
cells have been shown to express α-smooth muscle actin (de Kater, Shahsafaei, and 
Epstein 1992). α-smooth muscle actin is an actin isoform that is expressed in vascular 
smooth muscle cells and myofibroblasts, giving cells significant contractile ability 
(Wang, Zohar, and McCulloch 2006).  Experiments have suggested that altering the TM 
actin by changing cell shape and altering the geometry of the trabecular outflow pathway 
can influence the outflow resistance (Wiederholt, Thieme, and Stumpff 2000, Tian et al. 
2000). However, since cytoskeletal agents can affect many different cell types along the 
trabecular outflow pathway, whether trabecular beams and their TM cells are important 
in regulating outflow resistance remains unclear.  
 
Juxtacanalicular tissue 
 Juxtacanalicular tissue (JCT), the region that resides immediately underneath the 
inner wall of SC endothelial cells, is filled with extracellular matrix composed of 
collagen type I, III, IV, V and VI (Lütjen-Drecoll et al. 1989, Marshall, Konstas, and Lee 
1990, 1991), elastin (Gong, Trinkaus-Randall, and Freddo 1989), fibronectin (Gong, 
Tripathi, and Tripathi 1996), laminin (Marshall, Konstas, and Lee 1990), dermatan 
sulfate, chondroitin sulfate, and hyaluronic acid (Gong, Tripathi, and Tripathi 1996). Due 
to JCT’s numerous micron-size empty spaces, studies have estimated that JCT alone 
could not present significant outflow resistance unless these regions were filled with 
extracellular matrix gel (Ethier et al. 1986, Murphy, Johnson, and Alvarado 1992, Seiler 
and Wollensak 1985). However, Gong and colleagues (Gong et al. 2002)  have showed 
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that even with the quick-freeze/deep-etch technique, which can better preserve the 
extracellular matrix, micron-size empty open spaces are still observed, suggesting that 
other mechanisms may play a role in regulating the outflow resistance. 
 
Inner wall endothelium of Schlemm’s canal 
The endothelial cells of the inner wall of SC (SCECs) are spindle-shaped with a 
central nuclear bulge and tapering rounded edges (Figure 1.3). The cell’s long axis is 
parallel to the circumference of SC with a length of 40-100 μm, a width of 2-20 μm, a 
thickness of 0.4-1 μm in the non-nuclear region and 4-7 μm in the nuclear region 
(Johnson 2006, Vargas-Pinto et al. 2015). For many years, investigators were puzzled by 
the developmental origin of the SCECs, in which they exhibited a mixed phenotype 
similar to both blood and lymphatic vasculatures (Tripathi 1974, Ramos, Sumida, and 
Stamer 2009). It wasn’t until recently that Kizhatil and colleagues (Kizhatil et al. 2014) 
using genetic lineage tracing and fluorescent reporter genes, have shown that SC is a 
unique vessel with a combination of blood and lymphatic vascular phenotypes that forms 
by a novel developmental process, which they termed “canalogenesis”. SCECs have been 
shown to express both blood vascular and lymphatic biomarkers such as CD31, CD 34, 
VE-Cadherin, Vegfr-3, and Prox-1, but lack Lyve1 expression (Ramos et al. 2007, Park 
et al. 2014, Aspelund et al. 2014, Kizhatil et al. 2014, Truong et al. 2014). 
Morphologically, SCECs are a continuous endothelium that forms connections with 
adjacent SCEC and underlying JCT cells, and that are supported by a discontinuous 
basement membrane. In comparison, blood vasculature has a discontinuous endothelium 
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with a continuous basement membrane while lymphatic vasculature has a discontinuous 
endothelium with a discontinuous basement membrane (Grierson et al. 1978, Raviola and 
Raviola 1981, Gong, Tripathi, and Tripathi 1996, Bhatt, Gong, and Freddo 1995, Ethier 
2002). 
Since SCECs provide the final barrier to the trabecular outflows prior to drainage 
into the lumen of SC, they were often considered as the prime candidates in generating 
outflow resistance (Johnson 2006, Overby, Stamer, and Johnson 2009). However, as 
discussed in the following text, more work remains to determine the importance of this 
cell layer. During the aqueous humor outflow, transendothelial pressure gradient crossing 
through the SCECs causes formation of giant vacuoles (GVs) (dynamic outpouchings of 
the SCECs (Grierson and Lee 1977), micron-size pores within the SCEC (intracellular 
pores), or between the SCECs (paracellular pores) (Ethier et al. 1998). Current theory 
postulates that the formation of GVs leads to thinning of the SCECs, which is necessary 
for intracellular and paracellular pore formation that provide the outflow pathway across 
the SCECs (Overby et al. 2014, Vargas-Pinto et al. 2015). The intracellular pores are 
membrane-lined and pass from the basal to apical side of the cells where the inner and 
outer cell surface membranes have come together and fused. Paracellular pores, on the 
other hand, are speculated to form because of tight junction simplification due high 
strains at the periphery of the SCECs caused by the basal-to-apical aqueous humor 
outflow (Ye et al. 1997, Braakman et al. 2014). The formation of these pores, however, 
would theoretically make SCECs a low resistance barrier (Bill and Svedbergh 1972). 
However, studies using chemical agents have showed that the amount decrease in 
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outflow resistance by disrupting the SCECs was significantly more than that of only 
considering the resistance through the pores (Bill, Lutjen-Drecoll, and Svedbergh 1980, 
Hamanaka and Bill 1987). Nevertheless, recent study has shown that in vitro SCECs 
from glaucoma patients have higher cell stiffness, which may resulted in decrease pore 
formation and contribute to elevated outflow resistance in POAG patients (Overby et al. 
2014).  
 Previous assumptions of outflow resistance have been that the total resistance is 
equal to the resistance of each tissue stratum added in series. However, as discussed 
earlier, the sum of apparent outflow resistance of the inner wall endothelium of SC and 
JCT were much lower than the measured total outflow resistance. Thus, previous 
resistors-in-series model cannot explained the observations unless the estimated 
resistance is higher than the observed opening size of the outflow tissue based on 
histological sections, or a synergistic model of outflow resistance is considered. In the 
synergistic model, investigators have theorized that it is the hydrodynamic interaction 
between the pore density, giant vacuole size, and JCT that resulted in the overall outflow 
resistance contribution (Overby et al. 2002, Overby, Stamer, and Johnson 2009). This 
was termed as funneling effect or model, which assumed that the aqueous humor outflow 
from JCT through the pores of the SCECs is non-uniform, which decreases the effective 
outflow area and in turn increases the effective hydraulic resistance in this region 
(Overby et al. 2002). Studies that support this conclusion have shown that drug-induced 
SCECs and JCT separation without disrupting the SCECs resulted in a significant 
reduction in outflow resistance and the effects were reversible with removal of drugs 
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(Sabanay et al. 2000, Sabanay et al. 2004, Tian et al. 1998). Additionally, the funneling 
model may explain the “washout effect” observed in non-human animal studies, which is 
the volume-dependent decrease in outflow resistance found during the anterior chamber 
perfusion (BARANY 1954, Yan et al. 1991, Van Buskirk and Brett 1978, Kiland, Gabelt, 
and Kaufman 2011, 2005, Scott et al. 2007, Lu et al. 2011). These results suggest that 
physical connectivity between the SCECs and JCT may be the important regulator of the 
funneling effect (Scott et al. 2007, Overby et al. 2002). However, further studies are 
needed to verify the funneling model. Furthermore, there is limited knowledge on 
whether the cell surface extracellular matrix, the endothelial glycocalyx, can contribute to 
the outflow resistance. 
 
Endothelial glycocalyx 
The glycocalyx is comprised of glycoproteins bearing acidic oligosaccharides and 
terminal sialic acids, proteoglycans, and glycosaminoglycans (GAGs) (Reitsma et al. 
2007). Previous studies have used electron microscopy to examine the structure of 
glycocalyx in blood vessels, including rat myocardial capillaries (van den Berg, Vink, 
and Spaan 2003), rat aorta (Devaraj et al. 2009), and human umbilical vein (Chappell et 
al. 2009). It is well-known that flow-induced shear stress acting on vascular endothelial 
cells leads to cell elongation and cell alignment in the direction of flow (Dewey 1983, 
Dewey 1984, Remuzzi et al. 1984). Surprisingly, even the relatively low shear stress in 
SC leads their endothelial cells to align with the flow (Ethier, Read, and Chan 2004). This 
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alignment is mediated by the glycocalyx and "the presence of the glycocalyx is necessary 
for the endothelial cells to respond to fluid shear" (Yao, Rabodzey, and Dewey 2007). 
The glycocalyx also plays an important role in the mechanotransduction of fluid 
shear stress (Tarbell and Ebong 2008, Tarbell 2010, Weinbaum, Tarbell, and Damiano 
2007, Pries, Secomb, and Gaehtgens 2000), particularly as related to activation of 
endothelial nitric oxide synthase (eNOS) and subsequent nitric oxide (NO) release. The 
latter mediates flow-induced vasodilation in vascular endothelium. Modifications to the 
glycocalyx by removal of heparan sulphate, hyaluronic acid, or sialic acid abolishes the 
release of nitric oxide and consequent flow induced vasodilation (Tarbell and Ebong 
2008). However, the structures and role of glycocalyx in regulating outflow resistance in 
the eyes remains understudied. 
Richardson (Richardson 1982) previously examined the presence of glycocalyx 
(he labeled them as GAGs) on the surface of the aqueous outflow pathway in feline using 
ruthenium red, but that label is known to collapse the glycocalyx (Tarbell and Ebong 
2010), and thus the detailed structure, and distribution of glycocalyx layer in the aqueous 
outflow pathway have remained unclear. Therefore, an understanding of the glycocalyx 
layer expression will allow us to better understand its role in regulating the outflow 
resistance 
 
Current glaucoma medications 
Current glaucoma medications reduce IOP either through reducing the rate of 
aqueous humor production with beta-blockers, alpha-agonist or carbonic anhydrase 
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inhibitors or by increasing the uveoscleral outflow with prostaglandin analogues. Given 
that aqueous humor is the source of nutrition for the avascular lens, cornea, and 
trabecular meshwork, reducing aqueous humor production can potentially produce 
serious side effects. On the other hand, while prostaglandin analogues are widely 
prescribed, nearly half of all patients ultimately required addition of non-prostaglandin 
drugs as part of the treatment plan. It appears that the culprit of rising IOP is due to 
continuing degradation of the trabecular outflow pathway over time (Kopczynski and 
Epstein 2014).  
Although currently there are no FDA approved drugs that target the trabecular 
outflow pathway, several new drug classes that target this pathway are currently in 
clinical development. One of the most extensive studied drug classes is Rho-kinase 
inhibitor, a cytoskeletal agent. Numerous studies have looked at the effect of cytoskeletal 
agents that target the cytoskeleton of the cells in the trabecular outflow pathway, 
including cytochalasin (Johnson 1997, Kaufman and Erickson 1982, Tian et al. 1999), 
latrunculin-B (Ethier, Read, and Chan 2006, Sabanay et al. 2006), H-7 (Bahler et al. 
2004, Sabanay et al. 2004) and Y27632 (Honjo, Tanihara, et al. 2001, Lu et al. 2008, Rao 
et al. 2001, Tian and Kaufman 2005, Waki et al. 2001), which augment aqueous humor 
outflow facility. Together, these agents have shown that aqueous humor outflow 
resistance and IOP can be modulated through actomyosin cytoskeleton reorganization. In 
particular, Y27632, a Rho-kinase inhibitor, has showed great promise in decreasing 
aqueous humor outflow resistance and IOP without any apparent toxic effects on ocular 
tissues.  
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Rho-kinase inhibitor Y27632 
The Rho subfamily of small GTPases is critical in regulating actomyosin 
cytoskeletal organization, cell adhesion, and cell motility (Kaibuchi, Kuroda, and Amano 
1999, Somlyo and Somlyo 2000, Fukata, Amano, and Kaibuchi 2001). Rho-associated 
coiled coil-forming protein kinases (ROCKs), downstream effectors of Rho, are 
important for regulating focal adhesions and stress fiber formation in cultured fibroblasts 
and epithelial cells through modulation of myosin phosphatase activity (Nakagawa et al., 
1996; Riento et al., 2003). Y27632 has been identified as a selective inhibitor for the 
ROCKs isoforms ROCK-I and ROCK-II (Davies et al. 2000, Uehata et al. 1997, Ishizaki 
et al. 2000), which regulates myosin light chain (MLC) phosphorylation by increasing 
MLC-phosphatase activity and decreasing MLC phosphorylation (Fukiage et al. 2001, 
Kaibuchi, Kuroda, and Amano 1999, Rosenthal et al. 2005). As a result, cells become 
less contractile and decrease the quantity of actin stress fibers and disassembly of focal 
adhesions (Honjo, Inatani, et al. 2001, Rao et al. 2001).  
Studies have shown that Y27632 increases outflow facility (lower outflow 
resistance) in non-human models, including live rabbits (Honjo, Tanihara, et al. 2001, 
Waki et al. 2001) and monkeys (Tian and Kaufman 2005); and enucleated porcine (Rao 
et al. 2001), bovine (Lu et al. 2008), and monkey eyes (Lu et al. 2011). Common 
morphological features observed alongside increased outflow facility include the 
expansion of the subendothelial extracellular matrix in the JCT, inner wall SC/JCT 
separation; and distension of SCECs. Similar structural changes were observed when 
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using other cytoskeletal disrupting agents in non-human eyes as well (Tian et al. 1999, 
Sabanay et al. 2006). However, the structural changes induced by Y27632 and their 
association with lowering outflow resistance in human eyes remains unclear. 
Similar hydrodynamic and morphological changes were reported in the aqueous 
humor outflow pathway after washout- and Y27632-induced decreases in outflow 
resistance in both bovine and monkey eyes (Lu et al. 2008, Lu et al. 2011, Scott et al. 
2009). However, studies have shown that human eyes do not exhibit washout effect 
(Erickson-Lamy et al. 1990, Scott et al. 2007). In addition, other studies in enucleated 
human eyes have demonstrated that more than 2 hours of perfusion with either H-7 
(Bahler et al. 2004) or latrunculin-B (Ethier, Read, and Chan 2006) resulted in a much 
smaller increase in outflow facility (37% and 64%, respectively) compared to the 2 to 4-
fold increase in outflow facility observed in non-human eyes (Sabanay et al. 2000, 
Sabanay et al. 2004, 2006, Tian et al. 1999). Further studies using Y27632 in normal 
human and animal model of glaucoma eyes as well in vitro studies of inner wall SCECs 
are important to shed additional light on understanding the role of the inner wall region of 
SC on regulating the outflow resistance. 
 
Aims of the dissertation 
Aim 1: Determine the effect of Rho-kinase inhibitor on aqueous humor dynamics 
and morphology of the trabecular outflow pathway in normal human and laser-induced 
ocular hypertensive monkey eyes. (Chapter 2 and 3)      
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Aim 2: Develop an in vitro 3D microfluidic system to model the inner wall 
endothelium of Schlemm’s canal and the effect of Rho-kinase inhibitor on cell 
cytoskeleton and barrier function (Chapter 4) 
 
Aim 3: Determine the morphological structure, distribution, and thickness of the 
endothelial glycocalyx in the aqueous humor outflow pathway of human and bovine eyes. 
(Chapter 5) 
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Figure 1.1: Aqueous humor outfow pathway 
(Left) Schematic of the anterior segment of the eye showing the direction of the aqueous 
humor outflow. (Right) Enlargement of the irodocorneal angle showing the trabecular 
and uveoscleral outflow pathways . Modified from (Llobet, Gasull, and Gual 2003) 
  
17	
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Figure 1.2: Light micrograph of a radial section through the inner wall of the 
Schlemm’s canal (SC) and the trabecular meshwork  
Arrows point to giant vacuoles in the inner wall endothelium of SC. JCT: 
Juxtacanalicular tissue; CTM: Corneoscleral trabecular meshwork; UTM: Uveal 
trabecular meshwork. Magnification bar: 5 μm. Modified from (Tamm 2009) ©Elsevier 
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Figure 1.3: Scanning electron micrograph of the inner wall of Schlemm’s canal as 
viewed from within SC  
The bulging structures are either giant vacuoles or nuclei. The arrowhead is pointing at a 
pore.  Modified from (Allingham et al. 1992) © ARVO. 
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CHAPTER 2 – EFFECTS OF Y27632 ON AQUEOUS HUMOR OUTFLOW 
FACILITY WITH CHANGES IN HYDRODYNAMIC PATTERN AND 
MORPHOLOGY IN HUMAN EYES  
 
Data presented in this chapter were accepted for publication in: 
Investigative Ophthalmology & Visual Science 2013 Aug; 54(8): 5859-70. 
The final publication is available at http://iovs.arvojournals.org. 
Authors: Chen-Yuan Charlie Yang, Ye Liu, Zhaozeng Lu, Ruiyi Ren, Haiyan Gong 
 
Introduction 
 The goals of this study are to determine the effects of Y27632 on aqueous humor 
outflow facility, hydrodynamic pattern, and morphology in enucleated human eyes. We 
hypothesize that similar to that in non-human eyes, an increase in outflow facility after 
Y27632 treatment is positively correlated with an increase in effective filtration length 
(EFL) in human eyes, which is regulated by morphological changes; however, it may 
take more time for human eyes to respond after Y27632 treatment because human eyes 
have stronger connections between the inner wall of Schlemm’s canal (SC) and 
juxtacanalicular tissue (JCT) compared to animal eyes (Overby, Stamer, and Johnson 
2009). To test our hypothesis, we perfused Y27632 for a short-duration (30 minute) 
under similar experimental conditions as our previous studies in bovine and monkey eyes 
(Lu et al. 2008, Lu et al. 2011). In addition, we perfused the eyes with Y27632 for a 
longer duration (3 hour). Fluorescent microspheres and confocal microscopy were used to 
visualize the change in outflow pattern; and light and electron microscopy were 
employed to investigate the morphological changes. 
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Materials and Methods 
Materials  
16 enucleated human eyes from anonymous donors without any known history of 
ocular diseases were obtained from National Disease Research Interchange (Philadelphia, 
PA) and Lions Eye Institute for Transplant & Research, Inc. (Tampa, FL). The mean 
donor age was 70 years (range, 43-90), and the mean postmortem time to the start of 
perfusion was 22 hours (all except 2 eyes were within 24 hours, range, 16-34). Each eye 
was confirmed to be grossly normal by examination under a dissecting microscope.  
The perfusate was Dulbecco’s phosphate-buffered saline (pH 7.3, Invitrogen, 
Grand Island, NY) containing 5.5 mM D-glucose (collectively referred to as GPBS). Red 
carboxylate-coated fluorescent microspheres (500 or 200 nm, Invitrogen, Grand Island, 
NY) at 0.002% v/v concentration were used to trace aqueous humor outflow patterns. 
The specific sizes and concentration of fluorescent microspheres were chosen for 
negligible obstruction of aqueous outflow through the trabecular meshwork (Johnson et 
al. 1990). To maintain consistency with our previous studies in bovine (Lu et al. 2008) 
and monkey (Lu et al. 2011), 50 µM concentration of Y27632 (Calbiochem, La Jolla, 
CA) in GPBS concentration was used in this study. 
 
Methods 
Ocular perfusion 
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The perfusion procedure was described in detail in our previous work (Scott et al. 
2009). All eyes were initially perfused with GPBS for 30 minutes at 15 mmHg to 
establish a stable baseline facility. Anterior chamber fluid from each eye was exchanged 
with either 5 mL of 50 µM Y7632 or GPBS, followed by perfusion of the same solution 
for 30 minutes (short-duration, n=3 per group) or 3 hours (long-duration, n=5 per group). 
To label the hydrodynamic outflow, anterior chamber fluid from all eyes was then 
exchanged for 5 mL of GPBS containing fluorescent microspheres followed by fixed 
volume perfusion of the same solution. Anterior chamber fluid from all eyes was then 
exchanged and perfusion-fixed at 15 mmHg with a modified Karnovsky’s fixative (2.5% 
glutaraldehyde and 2% paraformaldehyde, pH 7.3). After perfusion was completed, eyes 
were hemisected along the equator and immersed overnight in the same fixative for 
further processing. 
 
Confocal microscopy 
All fixed eyes were cut through the equator, and the vitreous body and lens of 
each eye were carefully removed. Anterior segments of the eyes were then divided into 
four quadrants (Temporal, Nasal, Superior and Inferior). Each quadrant was cut into 
frontal sections, along a plane tangential to the corneoscleral limbus and perpendicular to 
the ocular surface (Lu et al. 2008, Parc, Johnson, and Brilakis 2000). To visualize cell 
nuclei, sections were counter-stained with TO-PRO-3 or DAPI (Invitrogen, Carlsbad, 
CA). After three washes with PBS, sections were mounted and examined using a 
confocal microscope (Carl Zeiss 510, Axiovert 100M Laser Scanning Microscope, 
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Heidelberg, Germany) for image scanning and capturing. Fluorescent microspheres were 
visualized using a multi-track channel system with a 20X objective lens. Images were 
taken in all sections containing SC, so that the distribution of the tracer along the inner 
wall and the TM could be properly analyzed.   
EFL is the one-dimensional equivalent to effective filtration area; this was 
measured as previously described (Lu et al. 2008, Lu et al. 2011, Scott et al. 2009). The 
total length (TL) of the inner wall of SC and fluorescent-decorated length (FL) of the 
inner wall of SC in each image were measured using LSM Image Browser (Version 4.2, 
Carl Zeiss), and the average percent effective filtration length (∑EFL / ∑TL) in each eye 
was calculated (Figure 2.1A). A minimum of 16 images per eye from all four quadrants 
were measured and analyzed.  
TM thickness (the length from the innermost uveoscleral beam to the inner wall 
endothelium of SC) was measured to determine the effect of Y27632 on “relaxing” the 
TM. Confocal images of long-perfusion Y27632 and long-perfusion GPBS from previous 
EFL measurements were randomly selected (including both anterior and posterior parts 
of TM) and only included for measurement if the whole meshwork was observed. TM 
was designated as either a high-tracer (EFL ≥ 60%) or low-tracer (EFL ≤ 40%) region.  
Each image was measured at three different locations, and the average thickness of TM in 
high-tracer and low-tracer regions of each eye was then calculated and analyzed (Figure 
2.1B). Tissue sections analyzed by confocal microscopy were further processed for light 
and electron microscopy.   
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Light microscopy 
Tissue sections were post-fixed in 2% osmium tetroxide and 1.5% potassium 
ferrocyanide for 2 hours, dehydrated in an ascending series of ethanol, and embedded in 
Epon-Araldite. Semi-thin sections (3 µm) were cut and stained with 1% Toluidine Blue 
(Fisher Scientific, Pittsburgh, PA). Light micrographs were taken using a 20X objective 
along the inner wall of SC. All the measurements described below were taken from eight 
tissue sections per eye from a minimum of three quadrants (accounting for a SC length 
between 7.6 to 12.5 mm per eye) of all eyes with long-duration perfusion with either 
Y27632 or GPBS. JCT was defined as the tissue underlying SC, extending from SC 
endothelial cells to the empty space adjacent to the first trabecular beams (Ten Hulzen 
and Johnson 1996, Alvarado, Yun, and Murphy 1986). The average JCT thickness (∑JCT 
area / ∑JCT length), percent JCT empty space (∑empty space / ∑JCT area, determined 
using a custom written ImageJ macro) and loose JCT thickness (average JCT thickness × 
percent JCT empty space) of each eye were calculated (Figure 2.1C). Giant vacuoles 
(GV) were identified if their diameter was ≥ 2 µm and appearance was  “smooth-walled, 
round, oval, reniform, or crescentic spaces”(Grierson and Lee 1977). GV were counted 
along the inner wall of SC and the number of GV per mm of SC length (∑GV number / 
∑SC length) was calculated. All the images were taken and measured in a masked 
manner to avoid biased analysis. 
 
Electron microscopy 
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Ultrathin sections (90 nm) were cut with an ultramicrotome, counterstained with 
uranyl acetate and lead citrate, and examined using transmission electron microscopes 
(Philips EM300, Eindhoven, Netherlands or JEOL JEM-1011, Tokyo, Japan). Electron 
micrographs were taken randomly at different quadrants along the inner wall of SC. 
Morphology of the inner wall and JCT were analyzed and compared. The average JCT 
thickness of high-tracer and low-tracer regions was calculated from pooled images 
(n=107) from all eyes (∑JCT area / ∑JCT length) and compared between the Y27632 and 
GPBS groups. In region where fluorescent tracers were observed on both basal and apical 
side of the SC endothelium, serial-sections were performed to understand how tracer 
crosses the pores of the SC inner wall, where pores are considered paracellular pores if 
cell-cell junctions were observed, otherwise they are considered intracellular pores. 
 
Statistical methods 
Two-tailed Student’s t-test and linear regression analysis were applied with a 
required significance level of p ≤ 0.05. All data are expressed as Means±SEM. 
 
Results 
Outflow facility 
The outflow facility for the short-duration (30 minutes) Y27632 and GPBS 
groups (n=8 each) were calculated by combining the 30 minutes data points from both 
short-duration (n=3 each) and long-duration groups (n=5 each). An increase in outflow 
facility in the short-duration Y27632 group (29.0±10.6%) was higher than in the GPBS 
28	
group (5.2±4.5%), but not reached statically significance (p = 0.07, unpaired t-test) 
(Figure 2.2A).  However, outflow facility was found significantly increased in the short-
duration Y27632 group compared to its own baseline facility (p = 0.03, paired t-test) 
(Figure 2.2B).  
A significant increase in outflow facility was found following the long-duration (3 
hours) of Y27632 treatment (60.6±16.9%) compared to the GPBS group (-8.0±9.1%) (p = 
0.01, unpaired t-test, Figure 2.2A) and compared to its own baseline (p < 0.05, paired t-
test) (Figure 2.2B). In contrast, perfusion with GPBS for 3 hours had no significant 
differences in outflow facility compared to its own baseline (p = 0.5, paired t-test, Figure 
2.2B). 
 
Flow pattern and trabecular meshwork thickness 
 Segmental distributions of tracers in TM were observed in all eyes (Figure 2.3A, 
C, E, G vs. B, D, F, H). Fluorescent tracers often reached the inner wall of SC at the 
region near the collector channels, rather than the regions further away from them. 
However, not all the inner wall regions adjacent to the collector channels had tracers pass 
through (Figure 2.3B, F). The long-duration Y27632 group displayed an overall increase 
in tracer quantity and area along the inner wall of SC compared to control group (Figure 
2.3). Confocal image analysis revealed that long-duration Y27632 has significantly 
higher EFL compared to long-duration GPBS and short-duration Y27632 groups 
(63.6±5.8 vs. 46.2±4.8 vs. 39.9±5.8 %) (Figure 2.4A). No significant difference in EFL 
was found between short-duration Y27632 and its control groups. On average, long-
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duration Y27632 increased EFL by 38% compared to its control. Moreover, TM 
thickness was found to increase in the high-tracer region compared to low-tracer region 
in both long-duration GPBS (95.7±6.5 vs. 82.1±5.8 μm, p = 0.023) and long-duration 
Y27632 (92.0±6.3 vs. 73.7±4.8 μm, p < 0.01) (Figure 2.3, 2.4B). 
 
Morphology of the inner wall of SC and juxtacanalicular tissue  
To determine the Y27632 associated inner wall/JCT structural changes, we 
analyzed on average 26% (range, 21-30%) of SC circumference and its underlying JCT 
per eye (based on 36 mm in SC circumference (Moses 1979)) using bright field 
microscopy. While no obvious inner wall/JCT separation was observed at light 
microscopy level, JCT expansion can be seen in a few regions along the SC in both long-
duration Y27632 and long-duration GPBS groups (Figure 2.5A). Detailed morphological 
analysis showed that average JCT thickness was significantly higher in long-duration 
Y27632 group compared to long-duration GPBS group (10.0±0.5 vs. 8.0±0.3 μm, p < 
0.01, Figure 2.5B). However, there were no significant differences in JCT optically 
empty space (GPBS: 40.0±3.7 vs. Y2732: 44.83±4.3 %, p > 0.05) or GV numbers 
(GPBS: 17±3 vs. Y27632: 19±3 per mm SC length, p > 0.05) between these two groups.  
By electron microscopy, we were able to visualize fluorescent tracers at the JCT 
regions and found that tracers accumulate mostly at loose JCT regions (more optically 
empty space), while fewer tracers and pigments accumulate at the dense JCT regions 
(Figure 2.6A). This indicated that high-tracer regions (more flow) were predominately 
loose JCT regions. Further analysis showed that an increased JCT thickness in the high-
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tracer regions compared to low-tracer regions for both long-duration Y27632 (high-
tracer: 8.6±0.8 μm, n=24 vs. low-tracer: 6.1±0.6 μm, n=33; p < 0.05) and GPBS (high-
tracer: 10.2±0.9 μm, n=15 vs. lower-tracer 3.9±0.3 μm, n=35; p < 0.001) groups (Figure 
2.6B). Furthermore, the low-tracer regions of the Y27632-treated eyes have significantly 
higher JCT thickness compared to the GPBS group (p < 0.01) (Figure 2.6B). In some 
JCT expansion regions, separation between the inner wall and JCT was observed. 
Interestingly, when we carefully examined the serial sections of the areas (N=15) where 
tracers located on both basal and apical side of the SC endothelium, we found pores in all 
of these areas; and they were all identified as paracellular pores (Figure 2.7A, B, C).  
 
Regression analysis 
Linear regression analysis showed that a significant positive correlation was 
found between EFL and change in outflow facility (with respect to baseline outflow 
facility) (R² = 0.511, p = 0.002) (Figure 2.8A). Furthermore, a strong positive correlation 
was found between loose JCT thickness and change in outflow facility (R² = 0.435, p = 
0.038) (Figure 2.8B). 
 
Discussion 
In this study, we investigated the effects of Y27632, a Rho-kinase inhibitor, on 
aqueous humor outflow facility, flow pattern (EFL), and morphology after 30 minutes 
and 3 hours perfusion in human eyes to test our hypothesis that EFL is positively 
correlated with outflow facility, which is regulated by morphological changes. Our major 
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findings are that (1) A significant increase in outflow facility was found after 30 minutes 
of perfusion with Y27632 compared to its own baseline in enucleated human eyes; 
however, it took a longer time (3 hours) for this increase in outflow facility to reach 
statistical significance compared to its control group; (2) The increase in outflow facility 
correlates positively with an increase in EFL, which is associated with an increased JCT 
thickness compared to the controls; (3) Aqueous humor outflow through the TM is 
segmental in human eyes, and an increased TM and JCT thickness was found in high-
tracer regions compared to low-tracer regions. Our data confirmed our hypothesis that an 
increase in outflow facility by Y27632 is positively correlated with an increase in EFL, 
which is regulated by morphological changes. 
 Previous studies have shown that Y27632 significantly increases outflow facility 
in non-human eyes after 30 minutes perfusion compared to their controls (Lu et al. 2008, 
Lu et al. 2011). This study demonstrated that although a significant increase in outflow 
facility was observed after 30 minutes perfusion with Y27632 in human eyes compared 
to its baseline, a longer perfusion time (3 hours) was necessary for Y27632 to 
significantly increase outflow facility to the level comparable with non-human eyes (Lu 
et al. 2008, Lu et al. 2011) compared to its controls (Figure 2.9A). This increase in 
outflow facility is associated with an increase in EFL. EFL was shown previously by our 
group to be an important parameter correlated with aqueous outflow facility in non-
human species (Lu et al. 2008, Scott et al. 2009, Battista et al. 2008, Lu et al. 2011, 
Swaminathan et al. 2013). Analysis of the EFL demonstrated a significant increase in 
long Y27632 treated-eyes compared to long GPBS or short Y27632 groups (Figure 
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2.4A), suggesting a more uniform distribution of flow can lead to a greater overall 
outflow facility. We also noted that the EFL increase (with respective controls) in human 
eyes is also smaller compared to bovine (Lu et al. 2008) and monkey (Lu et al. 2011) 
eyes (Figure 2.9B), which explains the smaller increase of outflow facility in human eyes 
compared to non-human eyes. Furthermore, our results demonstrated a positive 
correlation between EFL and an increase in outflow facility (R² = 0.511) in human eyes, 
which is similar to our previous studies with Y27632 in bovine (R² = 0.381)(Lu et al. 
2008) and monkey (R² = 0.375)(Lu et al. 2011) eyes. We have previously documented 
that a decrease in outflow facility in acute and chronic elevation of IOP in bovine(Battista 
et al. 2008) and monkey (Zhang et al. 2009) eyes was correlated with a decrease in EFL.  
Additionally, an inverse correlation between EFL and IOP was recently reported in an 
ocular hypotensive mouse model (Swaminathan et al. 2013). Collectively, our current and 
previous results suggest that the EFL is a valuable parameter to correlate with outflow 
facility and IOP across species.  
 Studies in non-human eyes have shown that drug-induced increases in outflow 
facility (Rao et al. 2001, Sabanay et al. 2004, 2006, Lu et al. 2008, Lu et al. 2011) share 
several common morphological features, including inner wall/JCT separation, JCT 
expansion, and increased in GV number. Interestingly, unlike our previous studies in 
non-human eyes where distinct inner wall/JCT separation can be observed by viewing the 
images at the light microscopy level, we were unable to distinguish morphological 
changes using the same method as we did previously. Instead, morphological analysis on 
the average JCT thickness was employed, which was determined by dividing the 
33	
measured total JCT area by the total JCT length per eye. This result showed that 3 hours 
of Y27632 treatment in human eyes induced expansion of the JCT by an average of 2 μm 
compared to its controls. Further analysis of JCT with electron microscopy revealed that 
high-tracers (more flow) regions have significantly higher average JCT thickness 
compared to low-tracer regions in both Y27632 and control groups. In addition, while 
there were no differences in JCT thickness of the high-tracer regions between Y27632 
and control groups, the Y27632 group had higher JCT thickness at the low-tracer regions 
compared to its controls. Together, the data suggests that overall JCT thickness increased 
following Y27632 treatment was the combination of an increase in high-tracer regions as 
well as increased JCT thickness at the low-tracer regions. Our data also demonstrated that 
loose JCT thickness was strongly correlative with changes in outflow facility (R² = 0.435, 
p = 0.038). Therefore, our results showed that the morphological change of increased 
expansion in the JCT is associated with increases in outflow facility and EFL, which is a 
similar change found in bovine and monkey eyes but to a lesser degree, which explained 
a less significant increase in outflow facility after Y27632 treatment in human eyes 
compared to non-human eyes. Additionally, our morphological findings support the 
funneling hypothesis (Overby, Stamer, and Johnson 2009) that the bulk of outflow 
resistance is generated within the JCT and that the attachment between the inner wall and 
JCT plays an important role in regulating outflow resistance. In this study, the overall GV 
numbers were similar between long-term Y27632 treatment and its control groups, which 
differ from previous studies in non-human eyes (Lu et al. 2008, Lu et al. 2011, Kameda et 
al. 2012, Rao et al. 2001) where GV number were increased in Y27632-treated eyes. The 
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lack of GV difference may be attributed to enhanced cell-matrix connectivity between the 
inner wall and JCT in human eyes compared to non-human eyes; additionally, JCT 
expansion reduces the resistance at the JCT/inner wall site and may in fact reduce the GV 
number and/or result in collapse of the GV, as suggested by Ethier et al.(Ethier, Read, 
and Chan 2006), which rendered GV unidentifiable under light microscopy.  
Lastly, a potential mechanism that could affect outflow facility is the cellular 
relaxation in the aqueous outflow pathway induced by Y27632. Rho-kinase is known to 
phosphorylate MLC by direct phosphorylation of MLC and also by promoting indirect 
phosphorylation by decreasing myosin phosphatase activity, resulting in smooth muscle 
contraction (Amano et al. 1996, Kimura et al. 1996, Kureishi et al. 1997). Recent studies 
have shown that Y27632 caused decreases in cell stiffness in both human TM (Rao et al. 
2005) and SC (Zhou et al. 2012) cultured cells, suggesting their role as modulators of 
outflow resistance. Our data demonstrated an increased TM thickness (relaxation) in 
high-tracer regions compared to low-tracer regions and a significant increase in the high-
tracer regions following Y27632 treatment, compared to its controls. Therefore, we 
postulate that the Y27632-induced increase in outflow facility in human eyes could be 
attributed to the concerted effect of increased TM and JCT expansion, with JCT 
expansion playing the major role.  
In addition, we carefully examined serial sections in multiple SC regions where 
tracers were found on both basal and apical sides of SC endothelium and found a pore in 
each of these regions. All pores found in these regions were identified as paracellular 
pores. These data support the hypothesis that the paracellular pathway may be the 
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predominant aqueous outflow pathway as indicated by an earlier study using cationized 
ferritin (Epstein and Rohen 1991). A previous study has shown that latrunculin-B treated 
eyes had increased pore size and density compared to control eyes (Ethier, Read, and 
Chan 2006). However, an in-depth analysis of the size and density of paracellular pores is 
out of the scope of this study. Future studies will need to determine the effects of Y27632 
on paracellular pores and whether pores play a role in contributing to aqueous outflow 
resistance. 
 In summary, Y27632 increase outflow facility in human eyes. However, 
compared to our previous reports in non-human eyes, this increase is smaller and took a 
longer time to reach statistical significance compared to its control groups. Similar to our 
previous studied in bovine and monkeys, the increase in outflow facility by Y27632 
correlates positively with an increase in EFL, which is associated with an increased 
expansion in the JCT, but to a lesser degree. Our current data in human eyes support our 
previous results in non-human eyes that EFL could serve as a novel parameter to 
correlate with outflow facility. 
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Figure 2.1: Measurement methods for effective filtration length, trabecular 
meshwork thickness, and juxtacanalicular tissue 
A: Measurement of the percent effective filtration length. The green line represents 
effective filtration length, and the white line represents total length (TL) of the inner wall 
of Schlemm’s canal (SC). The red represents the tracer distribution. The average percent 
effective filtration length (∑EFL / ∑TL) in each eye was calculated. 
B: Measurement of trabecular meshwork thickness. The green line represents the width 
of trabecular meshwork from innermost uveoscleral beam to the inner wall endothelium 
of SC. The red represents the tracer distribution.  
C: Morphologic analysis of JCT. Red line represents the JCT area, and the green line 
represents the length of JCT. JCT area was converted to binary image (below) to obtain 
the percent JCT empty space. The average JCT thickness (∑JCT area / ∑JCT length) and 
percent JCT optically empty space (∑JCT optically empty space / ∑JCT area) of each eye 
were calculated. 
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Figure 2.2: Outflow facility 
A: Changes in outflow facility between Y27632 treated groups (both 3 hours and 30min) 
and their respective GPBS controls.  An increase in outflow facility was observed in 
short-duration Y27632 group compared to the GPBS group (N=8 for each group, 
29.0±10.6% vs. 5.2±4.5%), but this increase did not reach statistical significance (p = 
0.07, unpaired t-test).  A significant increase in outflow facility was found after 3 hours 
perfusion with Y27632 compared to long- and short-duration control groups (p < 0.05, 
unpaired t-test). 
B: Time dependent changes of outflow facility between long-duration Y27632 treated 
and control eyes. The Y27632 group had a significant increase in outflow facility at 30 
min (N=8), 120 min (N=5) and 180 min (N=5) of perfusion with respect to their baseline 
(p < 0.05, paired t-test). In contrast, perfusion with GPBS at all time points had no 
significant differences in outflow facility compared to its own baseline (p > 0.05, paired 
t-test Figure 2.2B). Data are Means±SEM. 
*= p < 0.05 
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Figure 2.3: Tracer-decorated aqueous outflow pattern 
Aqueous outflow pattern through the trabecular meshwork (TM) region with or without 
collector channel (CC) in Y27632-treated and control eyes. Segmental distribution of 
fluorescent tracer was observed along the SC in both control (A-D) and Y27632-treated 
eyes (E-G). An increased TM thickness (double arrow) was found in the high-tracer (A, 
C, E, G) compared to the low-tracer regions (B, D, F, H). More fluorescent tracers were 
found near some CC ostia (A, E) but not the other regions near CC ostia (B, F) 
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Figure 2.4: Confocal microscopic analysis 
A: Average percent effective filtration length (EFL) in Y27632-treated and control eyes. 
A significant increase in EFL was found in long-duration Y27632-treated eyes compared 
to the controls (p < 0.05).  
B: Trabecular meshwork thickness (the length from the innermost uveoscleral beam to 
the inner wall endothelium). A significant increase of trabecular meshwork thickness in 
both long-duration Y27632 and long-duration control groups was found in the high-tracer 
regions than the low-tracer regions (p < 0.05).  
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Figure 2.5: Light microscopic analysis 
A: Morphological comparison. Juxtacanalicular tissue (JCT) expansion and compact 
regions were observed in both long-duration GPBS and long-duration Y27632 groups. 
SC: Schlemm’s canal. 
B: Juxtacanalicular tissue (JCT) thickness. A significant increase in average JCT 
thickness was found in long-duration Y27632 group compared to its control (p < 0.01). 
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Figure 2.6: Electron microscopic analysis  
A: Fluorescent microspheres (arrows) and pigments (arrowheads) were seen in the loose 
JCT region, which contains larger optical empty space (double arrow) than dense JCT 
(non-double arrow). No fluorescent microspheres were seen in the giant vacuoles (GV). 
SC: Schlemm’s canal; JCT: Juxtacanalicular tissue. 
B: JCT Thickness in high and low tracer regions. High-tracer regions had significantly 
higher JCT thickness compared to low-tracer regions in both long-duration Y27632 and 
GPBS groups (p < 0.05). Y27632 group had significantly higher JCT thickness compared 
to GPBS group at low-tracer regions (p < 0.01) while no difference was found at high-
tracer regions. 
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Figure 2.7: Analysis of tracer crossing the inner wall 
A: Tracers were observed across the inner wall of SC at various regions (arrows) at lower 
magnification.  
B. At a higher magnification, fluorescent tracers were observed on both basal and apical 
side of a cell-cell junction in the inner wall endothelium of SC. 
C. Serial sections were cut in the same cell-cell junction region shown as B. A 
paracellular pore was seen with tracers on both basal and apical side. 
SC: Schlemm’s canal. 
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Figure 2.8: Linear regression analysis 
A: A significant positive correlation was found between percent EFL and change in 
outflow facility (with respect to baseline). 
B: A significant positive correlation was found between loose JCT (L-JCT) thickness and 
change in outflow facility (with respect to baseline). 
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Figure 2.9: Comparison of outflow facility and effective filtration length in human, 
bovine, and monkey eyes 
A: Percent change in outflow facility in bovine (Lu et al. 2008), monkey (Lu et al. 2011), 
and human eyes after Y27632 treatment. Human eyes required a longer perfusion time 
with Y27632 to achieve the same percent increase in outflow facility as found in bovine 
eyes when perfused for a short duration, while this increase was still less than the level 
achieved in monkey eyes when perfused for a short duration with Y27632. 
B: Percent effective filtration length (EFL) in bovine (Lu et al. 2008), monkey (Lu et al. 
2011), and human eyes after Y27632 treatment. No change in EFL was found between 
short-duration Y27632 and its controls. An increase with respect to its controls in EFA 
after long-duration of Y27632 perfusion in human eyes is smaller compared to short-
duration Y27632 treatment in both bovine (Lu et al. 2008) and monkey (Lu et al. 2011) 
eyes. 
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CHAPTER 3 – HYDRODYNAMIC AND MORPHOLOGICAL CHANGES IN 
THE AQUEOUS HUMOR OUTFLOW PATHWAY AFTER Y27632 
TREATMENT IN LASER-INDUCED HYPERTENSIVE MONKEY EYES 
 
Introduction 
The goal of this study is to investigate the effects of Y27632 on the hydrodynamic 
and morphological changes in laser-induced ocular hypertensive monkey eyes. Due to 
differences in genetic variance, poor onset and pathological course of primary open angle 
glaucoma (POAG) in human eyes, the laser-induced chronic elevated intraocular pressure 
(IOP) primate models provide superior conditions for controlled experiments. First, the 
primate models are often considered the best because monkey eyes share similar 
anatomical structure as human eyes. Second, the chronic elevated IOP, similar to that 
found in POAG eyes, result in decreased aqueous outflow facility, development of optic 
disc cupping, and loss of retinal ganglion cells. Lastly, primate hypertensive eyes are 
responsive to glaucoma drugs, where IOP can be reduced with different dosing regime in 
a manner similar to humans (Gaasterland and Kupfer 1974, Radius and Pederson 1984, 
Quigley et al. 1987, Glovinsky, Quigley, and Dunkelberger 1991, Glovinsky, Quigley, 
and Pease 1993, Toris et al. 2000).  
Using a single color carboxylate-fluorescent tracer method, a previous study has 
shown that the available area for trabecular outflow, the effective filtration length (EFL) 
was significantly reduced in laser-induced ocular hypertensive monkey eyes (Zhang et al. 
2009). The morphological changes associated with reduction of EFL in laser-induced 
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hypertensive eyes were that the trabecular meshwork (TM) became denser with increased 
extracellular matrix deposition, and Schlemm’s canal (SC) became narrower or collapsed 
in the lasered regions of these eyes. The results of this study further support the findings 
of an earlier study using the same monkey model which indicated that lasered regions 
became impermeable to cationic tracer, and the flow was shifted to adjacent non-lasered 
regions (Melamed and Epstein 1987). Using similar methods, another study had showed 
that EFL was significantly increased after 30 min of Y27632 treatment in normal monkey 
eyes (Lu et al. 2011). The morphological changes associated with increased in EFL after 
Y27632 treatment are separation between inner wall of SC endothelium and 
juxtacanalicular tissue (JCT). The separation was mainly due to a disconnection between 
the JCT cells and between JCT cells and their extracellular matrix. 
Recently, a two-color fluorescent tracer technique was developed. This technique 
allowed us to label the hydrodynamic changes of aqueous humor outflow before and after 
changing intraocular pressure within the same eyes (Zhu, Ye, and Gong 2010, Zhu et al. 
2013), thus enabling us to analyze each eye as its own internal control. By adopting the 
two-color fluorescent tracer technique in conjunction with Y27632 treatment, this study 
aimed to further our understanding on the effects of Y27632 treatment in ocular 
hypertensive eyes. 
We hypothesize that Y27632 treatment increases outflow facility in laser-induced 
ocular hypertensive monkey eyes by increasing EFL in the non-lasered regions of the 
hypertensive eyes similar to Y27632-treated normal eyes, which is associated with 
morphologic changes. Additionally, Y27632 treatment would have no effects in the 
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lasered regions of the hypertensive eyes because damaged TM tissue becomes 
impermeable to aqueous outflow. The results of this study will provide valuable insights 
on understanding the potential mechanism of Rho-kinase inhibitors on lowering the 
increased aqueous outflow resistance in the monkey model with chronic elevated IOP. 
 
Materials and Methods 
Laser-induced ocular hypertensive model 
 A total of 13 cynomolgus monkey eyes from Dr. Carol Toris and Dr. Paul Russel 
(primates originated from Charles River Laboratories Inc. or Covance Research Inc.) 
were used in this study. Argon laser photocoagulation burns were made to the TM of 
monkey eyes to create unilateral chronic ocular hypertension as described previously 
(Toris et al., 2000) (N=6). Unpaired contralateral non-lasered eyes were served as 
normotensive control (N=7). Laser procedures were repeated for three treatments and had 
been performed at least 6 months before the study started. Intraocular pressure (IOP) was 
determined with a pneumatonometer after cornea anesthesia. The last measurement of 
IOPs on the day of sacrifice were used for the analysis and subsequent perfusion pressure 
minus the episcleral vein pressure (7 mmHg). 
 
Ex vivo ocular perfusion 
Enucleated eyes were perfused with Dulbecco’s’ phosphate-buffered saline 
containing 5.5 mM D-glucose (GPBS) at pre-mortem intraocular pressure minus 7 mmHg 
(episceral venous pressure) for 15-30 min until stable outflow facility was obtained. A 
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previously established two-color fluorescent tracer method (Zhu, Ye, and Gong 2010) 
was used to label the aqueous outflow patterns before (green tracer; 500 nm; 0.002%) and 
after 50uM Y27632 treatment (red tracer; 200 nm; 0.002%) (N=7). GPBS was perfused 
in non-treatment control group (N=6). The anterior chamber contents were exchanged 
prior to perfusion with the same perfusates (tracers, Y27632/GPBS, fixative). All eyes 
were perfused with a fixed volume of Y27632/GPBS and tracer solutions to control for 
the “washout effect”, a phenomenon in which a progressive decrease in outflow 
resistance occurs with the volume of perfusate flowing through the outflow pathways of 
non-human eyes (Scott et al. 2007, Overby et al. 2002). Eyes were perfusion-fixed with 
modified Karnovsky’s fixative (in phosphate buffer) and immersed-fixed with the same 
fixative before further processing. 
 
Fluorescent tracer distribution in the aqueous outflow pathway and trabecular 
meshwork thickness 
The eyes were hemisected along the equator and the vitreous humor, ciliary body 
and lens were removed. Macroscopic two-color tracer distribution from the TM sides was 
imaged through a 300mm lens on a 4000MP VersaDoc imaging system (Bio-Rad 
Laboratories, Hercules, CA). The fluorescent tracers were not observed from the 
perspective of the episceral veins due to the presence of scleral pigments. The tracers’ 
distribution in the TM served as guides to dissect the lasered eyes into non-lasered and 
lasered regions, which correspond to tracers and non-tracers regions, respectively) 
(Figure 3.1). For normal eyes, the anterior segments were divided equally into 16 
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segments. Each anterior segment was then cut into frontal sections, along a plane 
tangential to the corneoscleral limbus and perpendicular to the ocular surface (Lu et al. 
2008). The tissues were stained with DAPI (Thermo Fisher Scientific) to visualize cell 
nuclei. Confocal microscopy (Carl Zeiss 510, Axiovert 200M Laser Scanning 
Microscope, Carl Zeiss) was used to analyze the changes in effective filtration length 
(EFL) before and after Y27632 and control treatment. The method of EFL measurement 
was defined previously in chapter 2. The EFL approximates percent area of active 
outflow in which the tracers can cross the inner wall of SC because aqueous outflow 
through the TM is non-uniform (Scott et al. 2009). A new semi-computerized EFL 
measurement method was used here. EFL was determined first by drawing line profile 
immediately beneath the inner wall of SC using the blue channel (DAPI stained tissue) in 
ImageJ (NIH), and then by applying a preset intensity across the green and red channel 
(green and red tracers, respectively) to separate the tracers from the background while 
avoid user bias (Figure 3.2). Additionally, each confocal image was measured at two to 
three different locations for TM thickness (the length from the innermost uveoscleral 
beam to the inner wall endothelium of SC), and the average thickness of TM in normal 
eyes, and in lasered and non-lasered regions of the hypertensive eyes were calculated and 
analyzed.  
 
Morphological analysis of the trabecular outflow pathway by light and electron 
microscopy 
 After confocal microscopy examination, tissue segments were post-fixed in 2% 
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osmium tetroxide and 1.5% potassium ferrocyanide for 2 hours, followed by en-bloc 
staining with uranyl acetate, dehydrated in an ascending series of ethanol solution, 
infiltrated with propylene aside and embedded in Epon-Araldite. Semi-thin sections were 
cut and stained with 1% Toluidine Blue. Light micrographs of the trabecular outflow 
pathway were taken using Olympus FSX100 imaging system with a 40X objective to 
determine the density of giant vacuoles along the inner wall of SC. Ultra-thin sections 
were cut and ultrastructure of the inner wall SC and JCT regions were examined with a 
transmission electron microscope (JOEL JEM-1011, Tokyo, Japan). 
 
Statistical analysis 
A one-way ANOVA with post-hoc Tukey HSD was to analyze the EFL changes 
and TM thickness. The rest of the analysis used unpaired two-tailed Student's t-test. 
Results are shown as Mean±SD. 
 
Results 
Intraocular pressure and outflow facility 
The IOP was significantly higher in laser-treated eyes than normal eyes 
(36.8±16.1 vs. 21.9±3.5 mmHg, p=0.03) (Figure 3.3). To account for variable perfusion 
pressure, each eye’s outflow facility was normalized to its individual baseline facility 
determined from the end of first tracer (green tracer) perfusion. Outflow facility was 
significantly increased in both Y27632-treated and untreated normal eyes. While outflow 
facility was not increased in untreated hypertensive eyes, Y27632-treated hypertensive 
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eyes showed a trend of increase in outflow facility (Figure 3.4). 
 
Fluorescent tracer distribution in the aqueous outflow pathway and trabecular 
meshwork thickness 
Global fluorescent images from the posterior TM showed that fluorescent labeling 
was much more uniform in normal eyes compared to the lasered eyes (Figure 3.5). Using 
confocal microscopy, a segmental distribution of both green and red tracer was seen in 
the TM of normal and hypertensive eyes. Specifically, EFL was increased in normal eyes 
and non-lasered regions of hypertensive eyes in either Y27632-treated or control groups. 
In contrast, lasered-regions of hypertensive eyes did not show tracer labeling in either 
Y27632-treated or control groups (Figure 3.6A-F). There were no observable differences 
in EFL change as the result of Y27632 treatment (Figure 3.6G). 
Compared to normal control eyes, TM thickness was significantly smaller in all of 
the hypertensive eye groups. Compared to the Y27632-treated group, the TM thickness 
was significantly smaller in all the hypertensive eye groups except the non-lasered region 
of Y27632-treated hypertensive eyes (Figure 3.6 A-C, E, H). 
 
Morphology of the inner wall of SC and trabecular meshwork 
From light microscopy images, we observed that in both Y27632-treated and 
control groups, normal and non-lasered regions of hypertensive eyes had open SC while 
the lasered regions of both Y27632-treated and control hypertensive eyes had collapsed 
SC. In both non-lasered and lasered regions of hypertensive eyes, the TM was thinner. 
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Furthermore, the lasered regions appeared to have denser TM compared to the non-
lasered regions of hypertensive eyes (Figure 3.7). 
Ultrastructural analysis using electron microscopy showed significant inner wall 
SC/JCT separation in normal and non-lasered regions of hypertensive eyes in both 
Y27632 treated and control groups at high tracer regions. Moreover, the JCT appeared to 
be looser and more expanded in Y27632-treated eyes compared to the controls. In the 
lasered regions of both Y7632-treated and control eyes, there was a significant collapse 
of SC, fusing of trabecular beams with dense extracellular matrix, and loss of SC and TM 
cells (Figure 3.8). 
 
Discussion  
In this study, we investigated the effects of Rho-kinase inhibitor Y27632 on 
aqueous humor outflow facility, flow pattern, and morphology in laser-induced ocular 
hypertensive monkey eyes. In addition, our goal was to determine if Y27632-induced 
increase in EFL and associate morphology in the non-lasered regions of the hypertensive 
eyes is similar to Y27632-treated normal eyes. Lastly, we determined the effectiveness of 
the Y27632 in the lasered regions of the hypertensive eyes.  
First, we examined the effectiveness of the laser-induced hypertension eyes from 
the perspective of the IOP measurement. We found that not all the laser scarring of the 
TM induced an increase in IOP. Thus, we only used the eyes that had higher IOP in the 
lasered eyes compared to their contralateral non-lasered control eyes. An exception is that 
we had an additional unpaired Y27632-treated normal eye. The individual eye responded 
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differently to the laser treatment as indicated with a diverse range of changes in IOP 
measurement (Figure 3.3). Compared to a previous study in which the laser-induced 
hypertensive monkey eyes had IOPs ranged from 58-66 mmHg (Zhang et al. 2009), the 
hypertensive eyes in this study had rather modest increase in IOP (25-37 mmHg) with 
exception of one eye with higher IOP (68 mmHg).  
Second, a fixed-volume and variable perfusion-pressure methods were used to 
determine the outflow facility. A fixed-volume of perfusates allowed us to normalize the 
washout effect across different eyes. Washout effects were often found in non-human 
eyes (Scott et al. 2009) except for mouse eyes (Lei et al. 2011), in which there is a 
perfusion volume-dependent increase in outflow facility. This allowed us to more 
confidently assess the change in outflow facility induced by Y27632. However, one of 
the caveats associated with this method is that the difference in outflow facility of 
individual eyes resulted in different perfusion time (volume perfused = outflow facility x 
time). Consequently, the time under drug treatment was different for each eye, even 
though the drug volume remained the same. This means that the perfusion time for the 
drugs usually lasted for an average of 20-30 min in control eyes and greater than 1 hour 
in hypertensive eyes. In addition, we thought to mimic the original eye pressure 
environment by using different perfusion pressure for each eye based on each monkey’s 
last measured IOP prior to sacrifice. This allowed us to analyze the original state of the 
trabecular outflow pathway; however, this method also affects the outflow facility 
because outflow facility is pressure-dependent. Thus, the range of measured outflow 
facility was significantly increased and negatively impacted the statistical power of 
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comparing the Y27632 versus non-Y27632 treated eyes. Given these constraints, our 
outflow facility data showed that both Y27632 treated and untreated normal eyes had 
significantly increase in outflow facility while there was no significant increase in ocular 
hypertensive eyes for the duration of the perfusion. Although it is somewhat surprising 
that Y27632 did not induce a higher outflow facility increase compared to control eyes, 
we believe that this is likely due to a small number of eyes and different perfusion 
pressure. Furthermore, we found that although Y27632 was only minimally effective in 
increasing outflow facility in the hypertensive eyes, the outflow facility increase appeared 
to be higher in Y27632-treated eyes compared to untreated controls. This suggests that a 
combination of Y27632 treatment and washout together is more effective than washout 
only; and a longer perfusion of Y27632 is perhaps needed to induce an observable 
increase in outflow facility. An additional insight we found was that the outflow facility 
was decreased in all the groups after second tracer perfusion, suggesting the second tracer 
may partially obstruct the trabecular outflow pathway. Together, these findings would 
explain the minimal outflow facility changes that we observed in hypertensive eyes. 
Given that only 8-25% of the TM in hypertensive eyes were not laser-scarred (as 
observed from global fluorescent imaging), the obstruction would be worse in the 
hypertensive eyes if all the tracers were forced into smaller regions.  
Effective filtration length (EFL), a measurement method of outflow pattern, was 
shown previously as an important parameter correlated with aqueous outflow facility in 
non-human species (Lu et al. 2008, Scott et al. 2009, Battista et al. 2008, Lu et al. 2011, 
Swaminathan et al. 2013). In this study, however, there were no significant differences in 
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EFL change induced by Y27632 treatment in normal and non-lasered regions of 
hypertensive eyes. Three potential reasons could explain our findings. First, EFL was 
perfusion-pressure dependent, as shown by a previous study (Battista et al. 2008). 
Second, we did not observed significant difference in change in outflow facility between 
Y27632 treated and untreated normal eyes, which is positively correlated with EFL. 
Lastly, only small non-lasered regions were left without laser treatment in hypertensive 
eyes and small number of eyes available for this study negatively impacted the statistical 
power. Additionally, our data showed that lasered-regions of the hypertensive eyes did 
not have tracer labeling in both control and Y27632 groups, suggested that the laser-
scarred tissue was impermeable to fluid and the drug treatment would have no effect on 
this region. Zhang and colleagues (2009) had also observed the lack of fluorescent tracers 
in laser-regions as well. 
TM possesses smooth muscle-like properties (Wiederholt, Thieme, and Stumpff 
2000), and activating the Rho-kinase pathway is known to induce smooth muscle 
contraction (Amano et al. 1996, Kimura et al. 1996, Kureishi et al. 1997). Therefore, 
Y72632 could potentially relax the TM tissue and resulting in tissue expansion. We found 
that TM thickness was thinner in both lasered and non-lasered regions of the hypertensive 
eyes compared to normal eyes. The difference in the TM thickness between Y27632-
treated normal and non-lasered regions of hypertensive eyes was not significant, which is 
likely due to a small number of eyes and variation of individual eyes. We speculated that 
the laser-treatment caused an overall decrease in TM thickness, in both lasered and non-
lasered regions. In addition, we also observed that both normal eyes and non-lasered 
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regions of hypertensive eyes have open SC and expanded JCT. On the other hand, laser-
treatment caused significant SC/TM damage that resulted in collapsed SC, compacted 
TM, increased ECM, and SC/TM cell loss. Functionally, the laser-scarred tissue became 
“non-functional” and non-permeable to fluid as indicated by lack of fluorescent tracer. 
There are other means by which Y27632 and other Rho-kinase inhibitor lower 
IOP but were not explored in our ex vivo perfusion model. These additional mechanisms 
include increasing uveoscleral outflow (Toris, unpublished data) and lowering the 
episcleral venous pressure (Kiel and Kopczynski 2015). These studies suggest that even 
for advanced-stage glaucoma patients with significant cell loss in the TM, the Rho-kinase 
inhibitors may still have effect acting through these additional mechanisms. 
In summary, Y27632 can increase outflow facility in normal monkey eyes but is 
minimally effective in ocular hypertensive monkey eyes in the laser model. A longer 
period of Y27632 perfusion time is likely required in order to achieve a significant 
increase in outflow facility in hypertensive eyes. EFL was increased in normal and non-
lasered regions of hypertensive eyes; however, tracer labeling was not observed in the 
lasered regions regardless of the treatment. Lastly, the laser-treatment can cause SC and 
TM cell loss, which decreases the targeting area by Y27632. However, Rho-kinase 
inhibitors could still be clinically effective through increasing the uveoscleral outflow 
and lowering the episcleral venous pressure in vivo. 
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Figure 3.1: The lasered regions vs. non-lasered regions of hypertensive eyes 
A: Drawing of argon laser treatment locations as shown in blue crosses.  
B: Global fluorescent tracer imaging showing the tracer deposits in the trabecular 
meshwork of the eye. The non-lasered regions correspond closely with where tracer 
deposits were found while minimal tracers were found in the lasered regions. Scale bar: 
5mm. 
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Figure 3.2: Percent effective filtration length (EFL) measurement 
Percent effective filtration length was determined first by drawing a line profile (yellow 
line) immediately beneath the nucleus of the inner wall endothelial cells of Schlemm’s 
canal (SC) using the blue channel (DAPI stained) as a guide in ImageJ (NIH). Then a 
preset intensity was applied across the green and red channels (green and red tracers, 
respectively) to separate the tracers from the background. EFL = length of tracers 
reaching the inner wall SC / total inner wall SC length. Scale bar: 50 μm.  
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Figure 3.3: Intraocular pressure (IOP) between normal and hypertensive eyes 
The IOP was significantly higher in the hypertensive eyes than normal eyes (36.8±16.1 
vs. 21.9±3.5 mmHg, p=0.03) 
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Figure 3.4: Outflow facility with Y27632 treatment 
To account for variable perfusion pressure, each eye’s outflow facility was normalized to 
its individual baseline facility determined from the end of first tracer (green tracer) 
perfusion. Outflow facility was significantly increased in both Y27632-treated and 
untreated normal eyes from their baseline. While outflow facility was not increased in 
untreated hypertensive eyes, Y27632-treated hypertensive eyes showed a trend of 
increase in outflow facility. Mean±SD. *p < 0.01 
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Figure 3.5: Global fluorescent image in the trabecular meshwork (TM) 
Global fluorescent image in the TM showed that fluorescent labeling was much more 
uniform in normal eyes compared to both control and Y27632 treated lasered eyes. 
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Figure 3.6: Comparison of the effective filtration length and trabecular meshwork 
thickness between normal and hypertensive eyes with or without Y27632 treatment 
 
Confocal images from a normal control eye (A), aY27632-treated normal eye (B), a non-
lasered region of untreated hypertensive eye (C), and a non-lasered region of Y27632 
treated hypertensive eye (E) showed an increase in EFL. In contrast, lasered-regions of 
hypertensive eyes without Y27632 (D) or with Y27632 treatment (F) did not showed 
tracer labeling. Confocal images show that the TM thickness was smaller in a high-tracer 
region of the hypertensive eye (C, E) compared to similar region of a normal eye (A, B). 
G: EFL was increased in both Y27632-treated and untreated normal eyes and non-lasered 
regions of hypertensive eyes. However, there were no significant differences in EFL 
change between treated and non-treated groups. EFL was unchanged in both Y27632-
treated and untreated lasered regions of hypertensive eyes. 
H: Compared to high-tracer regions of normal control eyes, TM thickness was 
significantly smaller in all the hypertensive eye groups. Compare to Y27632-treated 
normal eyes, TM thickness was significantly smaller in all the hypertensive eye groups 
except the non-lasered region of Y27632-treated hypertensive eyes. 
*: p < 0.05; **: p < 0.01	
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Figure 3.7: Light microscopy images of the inner wall of Schlemm’s canal (SC) and 
trabecular meshwork (TM) 
In both Y27632 treated and control groups, normal and non-lasered regions of 
hypertensive eyes have open SC while the lasered regions of both Y27632-treated and 
control hypertensive eyes have collapsed SC. In both non-lasered and lasered regions of 
hypertensive eyes, the TM was thinner. Furthermore, the lasered regions appeared to 
have denser TM compared to the non-lasered regions of hypertensive eyes. Scale bar: 
50μm 
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Figure 3.8: Electron microscopy images of the inner wall of Schlemm’s canal (SC), 
juxtacanalicular tissue (JCT) and trabecular beams 
Significant separation between the inner wall of SC and JCT was observed in high tracer 
regions of normal and non-lasered regions of hypertensive eyes in both Y27632 treated 
and control groups. Moreover, the JCT appeared to be looser and more expanded in 
Y27632-treated eyes compared to the controls. In the lasered regions of both Y7632-
treated and control eyes, there were significantly collapse of SC, fusing of trabecular 
beams with dense extracellular matrix, and loss of SC and TM cells. Scale bar: 5μm 
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CHAPTER 4 - THREE-DIMENSIONAL MICROFLUIDIC MODEL FOR GIANT 
VACUOLE DYNAMICS AND SCHLEMM’S CANAL ENDOTHELIAL BARRIER 
FUNCTION 
 
Introduction 
This study aims to develop a three-dimensional (3D) microfluidic system to 
investigate the Schlemm’s canal endothelial cell functions in efforts to understand the 
relationship among Schlemm’s canal endothelial cell (SCEC) cytoskeleton, giant vacuole 
(GV) and pore formation, and SCEC barrier functions as the means to determine the role 
of SCEC in regulating aqueous humor outflow resistance. 
The actin cytoskeleton has been suggested to play an important role in regulating 
aqueous humor outflow resistance. Several studies have demonstrated that cytoskeleton-
disrupting agents (Sabanay et al. 2000, Tian and Kaufman 2005) can significantly reduce 
aqueous outflow resistance. Furthermore, both experimental and theoretical models have 
suggested that aqueous humor outflow through the SCECs can generate significant 
pressure gradients and shear stress that can influence the SCECs’ cytoskeletal 
architecture and induce nitric oxide release (Ethier, Read, and Chan 2004, Overby 2011, 
Ashpole et al. 2014). Recent cell culture studies have suggested that the altered 
cytoskeleton of SC endothelial cells from glaucomatous eyes may impact the ability of 
SCECs to form GV (Braakman et al. 2014, Overby et al. 2014, Stamer et al. 2014, Zhou 
et al. 2012). Moreover, POAG eyes were found to have reduced pore density in SCECs 
(Johnson et al. 2002). However, no previous works have defined the direct relationship 
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between the SCEC cytoskeleton and GV formation, and this tissue is further complicated 
by the lack of understanding of the GV formation and their importance in regulating the 
aqueous outflow in normal and POAG eyes (Overby, Stamer, and Johnson 2009). 
The inability to directly capture SCEC dynamics under physiological flow 
conditions has made it difficult to gain clear understanding of the cellular mechanisms 
that regulate outflow resistance. The use of microfluidics has recently emerged as a 
technology with the potential to impact cell biology research. More specifically, 
microfluidic-based cell culture allows control over the cellular microenvironment, 
including spatial and temporal gradients - a feat that cannot be managed in conventional 
cell cultures (Young and Beebe 2010). With this advantage, we have adopted a 
microfluidic-based 3D cell culture system with the capability to monitor real-time 
cellular activity in response to changes in the microenvironment (Vickerman et al. 2008, 
Vickerman and Kamm 2012). Unlike previous in vitro models studying GV dynamics 
(Alvarado et al. 2004, Pedrigi et al. 2011), this in vitro model system takes real-time 
images of GV dynamics in SCEC and fluid dynamics in an in vivo-like 
microenvironment, which enables us to investigate SCEC barrier functions, GV 
formation, and their responses to drug treatment. Additionally, our in vitro model allows 
for ultrastructural analysis of the cells and cell-cell junctions using electron microscopy. 
This system offers innovative ways to study cellular physiology and biomechanics of 
normal and glaucomatous SCECs in the future. 
 
Materials and Methods 
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Cell culture 
Human Schlemm’s canal endothelial cells (SCECs) were obtained from Professor 
Dan Stamer at Duke University, which were isolated from normal human donor eyes 
following published methods (Stamer et al. 1998). The SCECs were cultured in low-
glucose Dulbecco’s Modified Eagle’s Medium (DMEM, Corning) supplemented with 
10% fetal bovine serum (FBS, Gibco) and 1X penicillin-streptomycin-glutamine (PSG, 
Life Technologies). Experimental medium was cultured medium with 5% FBS instead. 
Two SCEC cell lines (SC73 and SC75) were used between passage 6 and 7. Human 
dermal lymphatic microvascular endothelial cells (LMECs) were purchased from 
commercial supplier (Lonza), cultured in EGM2-MV (Lonza), and used between passage 
6 and 7. Human umbilical vascular endothelial cells (HUVECs) were purchased from 
commercial supplier (Lonza), cultured in EGM2-MV (Lonza), and used between passage 
4 and 5. Experimental medium was same as cultured medium. 
LMECs and HUVECs were used as control cell type for the SCECs. Similar to 
the SCECs microenvironment, LMECs experience both transmural flow (basal to apical) 
and luminal flow parallel to the apical surface of the LMECs (Swartz MA 2001). Lastly, 
GV formation has always thought to be unique to SCECs and arachnoid granulation cells 
in vivo; however, a recent study has shown that other vascular endothelial cells such as 
HUVECs can also form GVs under basal to apical flow in vitro using etched-track filters 
(Pedrigi 2010). It is thus of interest to determine if HUVECs and LMECs can form GVs 
in our microfluidic system.  
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Microfluidic device design, fabrication, and implementation 
The microfluidic device design and patterned wafer was obtained from Professor 
Kamm at MIT, which is based on previous work from Vickerman et al. and 
Zervantonakis et al. (Vickerman et al. 2008, Zervantonakis et al. 2012) with 
modifications. The microfluidic device is made of polydimethyl siloxane (PDMS) using 
soft lithography with the SU-8 patterned wafer. It consists of two parallel channels 
connected by a gel cage for housing the extracellular matrix scaffolds. The present design 
is unique because it incorporates dual PDMS barriers that extend half the channel height, 
which creates a continuous hydrogel region throughout the microfluidic device, thereby 
creating a “post-less hydrogel cage device” (Figure 4.1). The device was sterilized using 
an autoclave, and then subjected to air plasma treatment (Harrick Plasma) to render the 
surface hydrophillic to promote irreversible bonding of the device with either glass 
coverslips (No.1) or PDMS-coated coverslips. Devices with HUVECs and LMECs used 
either glass coverslips or PDMS-coated coverslips while devices with SCECs only used 
PDMS-coated coverslips. The ECM hydrogel was injected into the middle scaffold 
region to form two isolated channels, which communicated solely through the hydrogel 
scaffold.  
Rat tail collagen type I at 2.5mg/mL or 3.5mg/mL (pH 7.4) was used as the  
scaffold. After injection of the scaffold, the device was placed in a humidifier at 37°C 
and 5% CO2 for 30-45min to allow gelation. Subsequently, coating solutions made of 
either fibronectin (100ug/mL) + matrigel (200ug/mL) in DMEM for SCECs or 
fibronectin (100ug/mL) in Endothelial Basal Medium (EBM) for HUVECs and LMECs 
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were pipetted into one media channel and incubated for an hour, then washed with 
respective cell culture media. Cells were then seeded into the devices through one 
channel (seeding concentration: LMECs: 2x106 cells/mL, HUVECs: 2x106 cells/mL , 
SCECs: 1.5x105 cells/mL, 40uL per device) and cultured for 2-4 days prior to subsequent 
experiement.  
 
Rho-kinase inhibitor Y27632 
Y27632 was purchased from EMD Millipore. Previous studies have also shown 
that Y27632 can affect the aqueous outflow resistance in animal and human models 
(Gong and Yang 2014) and decrease SCEC contractility in vitro (Zhou et al. 2012). For 
drug treatment group, cells were treated with 25μM of Y27632 in cell culture medium for 
one hour in static condition prior to subsequent dextran diffusion or flow experiment. 
 
Characterization of the diffusive permeability (Pd) 
Two-color 10kDa fluorescent dextran (Alexa Fluor 488 and 546) was used to 
study the change in diffusive permeability before and after drug treatment for each 
device. Dextran was mixed with experimental medium at a concentration of 12.5 μg/mL. 
The first-color dextran solutions (eg. Alexa 488) were exchanged and introduced into the 
endothelial-lined microfluidic channel under the steady-state condition. Fluorescent 
images containing the endothelial-lined channel and gel scaffold were taken after 1 hr 
(initial time point) and 2 hr (final time point) using a fluorescent microscope at 4.2X 
(Olympus FSX100) (Figure 4.2). The endothelial-lined channel was then applied with 
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25uM of Y27632 and incubated for 1 hr. After this, fluid was exchanged with second-
color dextran solutions and imaged as mentioned previously. Therefore, each device 
acted as its own internal control. Analysis of dextran transport was performed using 
ImageJ (NIH). Permeability was measured from quantifying the average intensity of the 
endothelial-lined channel and gel scaffold at the initial and final time points. Permeability 
coefficients PD were calculated based from previous published methods (Jeon 2014, Price 
2008, Huxley 1987) and modified into the following equation: 
𝑃! =  1𝐼!!!!!""#$ − 𝐼!!!"# ∙  𝐼!!!"# − 𝐼!!!"#∆𝑡 ∙ 0.2𝑐𝑚 
where !!!!!!!""#$!!!!!"# is the initial step increase in fluorescence intensity, !!!!"#!!!!!"#∆!  
is the initial rate of increase in fluorescence intensity as dextran diffuse into the gel 
scaffold, and the value of 0.2 cm is specific to this microfluidic system and determine 
from V/S, where V is the volume of the endothelial-lined microfluidic channel and S is 
the surface area of the endothelial monolayer (Figure 4.2). 
 
Characterization of hydraulic conductivity  
Following 2-3 days of cell seeding, thin PDMS strips were plasma treated and 
bound on top of the device gel injection ports to ensure flow only passed from basal to 
apical media ports during pressure gradient. 3mL syringe tubes (Monoject, Fisher 
Scientific) were used as reservoirs by inserting into the media channel ports and cell 
culture medium was added to establish a baseline, static condition for at least 30min. 
Then culture media was exchanged and incubated for 1 hour with either 25uM of Y27632 
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in culture media or culture media only as experimental or control groups, respectively. A 
basal to apical pressure differential of ΔP = 9.6 mmH2O was established by adding cell 
culture medium to the syringe tubes at the basal side and the flow lasted for 2 hour. 
Changes in culture medium level in reservoirs were measured every hour and were used 
to calculate changes in outflow facility and hydraulic conductivity (Lp) based from 
previously established methods (Vernella and Kamm 2012). To calculate the hydraulic 
conductivity (Lp), we first determined the Darcy permeability (K) of the collagen gel 
scaffold without the monolayer based from previous published methods (Sudo 2009): 𝑄 𝑡𝐴 = 𝐾𝜇  𝛥𝑃 𝑡𝐿  
where Q (t) is the volumetric flow rate measuring by the change in medium level in 
reservoirs, A is the surface area of the collagen gel scaffold, 𝜇 is the medium viscosity, L 
is the length of the collagen gel scaffold between two media channels, ΔP(t) is the change 
in pressure over time as medium level decreased. ΔP(t) = ρgΔz(t) where ρ is the medium 
density, g is the gravitational force, and Δz(t) is the medium height over time. After 
manipulating the above equation, the Darcy permeability (K) was obtained 
𝐾 =  − 𝜇𝐿𝐴!   ρgAt log 1−  𝑉(𝑡)𝐴!𝛥𝑧!  
where V(t) is the displaced medium volume in the reservoirs, Ar is the total area of the 
reservoirs surface area, and t is the length of the experiment, Δz0 is the initial medium 
height differences between basal and apical sides. Separate experiments were conducted 
with collagen gel and endothelial monolayer to obtain the new V(t) and Δz(t), which 
were measured. To calculate the Lp, the endothelial monolayer and collagen gel scaffold 
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were modeled as resistors-in-series: Rtot = Rgel + Rmonolayer. Since ΔP(t) = Q(t)R and Rgel = 𝜇𝐿/𝐾 , the total pressure drop experience by the endothelial monolayer is ΔPmonolayer = 
ΔPtot – vgel with monolayer Rgel where vgel with monolayer is the measured flow velocity per unit area of 
collagen gel surface area.  The hydraulic conductivity (Lp) of the endothelial monolayer 
can be estimated as follow 
𝐿!  =   𝑣!"# !"#! !"#"$%&'(𝛥𝑃!"#"$%&'(   
 
Immunofluorescence staining and image acquisition 
At the end of the flow experiment, 4% paraformaldehyde in PBS (PFA) of the 
same volume as above was exchanged at basal and apical channel side while maintaining 
basal to apical pressure gradient for 30 min, which then the reservoirs were removed and 
fixed with fresh PFA for additional 15 min at room temperature. For static conditions, the 
device was fixed with PFA for 15 min. All devices were washed with PBS, stained for 
cell membrane with Alexa Fluor 594 wheat germ agglutinin (WGA, Life Technologies) 
at 5 μg/mL for 10 min at room temperature. The devices were washed with PBS, 
permeabilized with 0.1% Triton-X 100 solution for 10 min, and blocked with 5% goat 
serum (Life Technologies) for 1 hr. They were then washed with PBS and stained for F-
actin filaments with Alexa Fluor 488 phalloidin (Life Technologies) at 1:40 dilution and 
cell nuclei with DAPI (Life Technologies) at 1:1000 dilution for 1 hr. All images were 
captured using a confocal microscope (Zeiss LSM 200M) and processed with ImageJ. 
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Quantification and visualization of giant vacuoles 
For GV quantification, a confocal slice was taken at 9 different gel regions 
approximately the same distance apart. The imaging z-plane was determined by scanning 
through in the z-direction 50 ± 15 μm (midpoint of the gel scaffold) to choose the 
imaging plane that showed GV with most number and largest dimension. Cells with GV 
were randomly selected for 3-dimensional reconstruction rendered from confocal z-stack 
using ImageJ. 
 
Matrix metalloproteinase (MMP) inhibitor GM6001  
Our initial experiments in the microfluidic devices found that SCECs appeared to 
exhibit several previously unidentified characteristics, including ECM digestion and cell 
migration, which are often associated with fibroblast rather than endothelial cells. To 
determine if the mechanism behind our observations was MMP-mediated, a broadband 
MMP inhibitor GM6001 (Calbiochem) was used. After SCECs were seeded in the device 
for 1 hour, the media was exchanged with either 20 μM or 50 μM of GM6001 in culture 
media and fed with same media until the day of flow experiment, when 5 μM of GM6001 
was used instead. 
 
Statistical analysis 
All data are reported as mean ± standard error of the mean. Paired Student’s t test 
was used to compare the diffusive permeability before and after Y27632 treatment.  
Unpaired Student’s t test was used to compare the rest of the data where each device is 
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one experimental condition. Tests with P ≤ 0.05 were considered to be statistical 
significant. 
 
Results 
Morphologically, LMECs and HUVECs appeared cobblestone-like while SCECs 
appeared spindle-shaped. Additionally, LMECs and HUVECs were much smaller in 
dimension compared to the SCECs (Figure 4.3A). After 3 days of seeding, LMECs and 
HUVECs formed confluent monolayer layer on collagen scaffold and coverslips. SCECs, 
however, appeared to lack contact inhibition, can form cable-like multicellular layer 
structure when seeded at higher density on collagen scaffold, and only sparsely covered 
the coverslips (Figure 4.3B).  
 
Diffusive permeability (Pd) 
LMECs exhibited significantly higher Pd to the passage of 10kDa dextran after 
Y27632 treatment (7.72x10-7±1.28x10-7 vs. 2.22x10-6±3.59x10-7 cm/s, n=6 pair, P < 0.01) 
(Figure 4.4). In contrast, neither SCECs nor HUVECs established barriers against 10kDa 
dextran even in the controls and appeared similar to scaffold-only devices (Figure 4.5). 
 
Hydraulic conductivity 
Based from experimental value, the calculated Darcy’s permeability for the 
collagen gel was 7.80E-13±4.52E-14 m2 (n=8). Interestingly, there was no significant 
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difference in hydraulic conductivity between Y27632-treated and untreated LMECs 
devices (0.79±0.11, n=8 vs. 1.18±0.19, n=10 μL/mmHg/min/cm2, P = 0.1) (Figure 4.6).  
 
F-actin visualization and giant vacuoles quantification  
The 3D design of the microfluidic devices allowed visualization of GVs using a 
single slice of confocal image without the need for 3D reconstruction. For LMECs, cells 
formed cell-cell junctions and Y27632 treatment significantly decreased F-actin staining 
intensity and F-actin fibers along the cells periphery (Fig 4.7A). Under flow condition, 
LMECs showed formation of GVs that exhibited dome-like elliptical cavity with the 
classic “signet ring” appearance in both control and Y27632 groups. Furthermore, GV 
number increased significantly in the Y27632 treated group compared to the controls 
(11±2 vs. 3±1 per mm, n=5 each, P < 0.01) (Fig 4.7A, B). Using 3D reconstruction, we 
observed that in some cases, multiple LMECs appeared to lift up in a continuous layer, 
similar to the cell-matrix separation observed in ex vivo perfused bovine eyes (Scott 
2007) (Figure 4.8). 
For SCECs, there were no cell-cell junctions and numerous gaps were observed 
both on the coverslips as well as on the collagen gel in both control and Y27632 treated 
groups. The control SCECs exhibited intense F-actin staining along the cell cortex while 
Y27632 treatment reduced the overall F-actin staining as well as cell cortex F-actin. 
Additionally, SCECs appeared more star-shaped with Y27632 treatment compared to 
ellipsoid shape in the control group (Figure 4.9). Lastly, some SCECs appeared more 
rounded after Y27632 treatment and GVs were not observed in either control or Y27632 
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treated cells (Figure 4.9).  
For HUVECs, cell-cell junctions were clearly observed on the coverslips, 
although gaps were seen between some cells as well. On the collagen gel, however, 
HUVECs did not appear to form a continuous monolayer, as numerous gaps were seen. 
Interestingly, the HUVECs monolayer appeared more intact with cells on the PDMS 
posts. Similar to SCECs, GVs were not observed in either control or Y27632 groups 
(Figure 4.10). 
 
The effect of GM6001 on SCECs migration and matrix digestion 
Our initial experiments found that SCECs can digest the ECM and migrate into 
collagen gel in as early as 2 days. In contrast, LMECs and HUVECs did not appear to 
digest their underlying collagen gel nor migrate into the gel for the duration of 
experiments (Figure 4.11). Therefore GM6001, a broadband MMP inhibitor was used to 
investigate the mechanism behind our observation. As expected, treatment with both 
20uM and 50uM GM6001 concentration produced less ECM digestion and less cell 
migration into the collagen scaffold (Figure 4.12).  
 
Discussion 
 We have developed and validated the current microfluidic system using LMECs 
to study the effect of Y27632 on GV formation and endothelial barrier functions. In 
addition, we have shown that Y27632 significantly reduced F-actin fibers and staining 
intensity and significantly increased GV formation, confirming our hypothesis that 
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decreasing cell actin cytoskeleton allow the cells to deform “easier” under a basal-to-
apical pressure gradient and result in more GV formed.  
Under static condition, the LMECs diffusive permeability was significantly 
increased with Y27632 treatment, suggesting that cell-cell junctions were disrupted and 
allowed more 10kDa dextran to diffuse across. This disruption of cell-cell junctions may 
allow more paracellular pores to form when the cell monolayer experiences basal-to-
apical pressure gradient. Under flow condition, the calculated Darcy’s permeability for 
collagen gel at 2.5 mg/mL concentration is very close to previous finding and within the 
predictive range of matrix-fiber theory (7.80E-13 vs. 9.48E-13 m2) (Wang and Tarbell 
2000). Additionally, the hydraulic permeability values we obtained were within one-fold 
difference compared to previous in vitro SCECs study using etched-track filters and 
supports the use of LMECs as a model cell line (Pedrigi et al. 2011). Interestingly, we did 
not find changes in LMECs hydraulic conductivity with Y27632 treatment. There are two 
potential explanations for our findings. First, low sensitivity in current measurement 
method was unable to detect small changes in hydraulic conductivity with Y27632 
treatment. Second, F-actin cytoskeleton changes in the endothelial monolayer induced by 
Y27632 treatment is not significant enough to changes the outflow resistance. We found 
that the average LMECs GV density in the microfluidic system was slightly smaller than 
the SCECs GV density in ex vivo perfused human eyes (11 vs. 17 per mm). However, we 
did not find an increase in GV number in Y27632-treated human eyes (Yang et al. 2013). 
The results suggests that while our microfluidic system is an useful tool to study the 
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mechanism of GV formation, other factors such as cell-cell connections between SCECs 
and JCT cells also play an important role in GV formation (Vargas-Pinto et al. 2015).  
Next, we extended the study using SCECs from normal donor eyes; however, our 
initial result showed that SCECs did not form a decent barrier nor were GVs formed 
under flow condition in both control and Y27632 treated cells. We hypothesized that 
SCECs were unable to form GVs due to lack of cell-cell junctions and/or gaps formed 
within the monolayer, causing the flow to direct to adjacent regions with less resistance. 
To confirm our hypothesis, HUVECs were used as a second control cell line, they form 
barriers in other microfluidic device with PDMS posts (Zervantonakis et al. 2012) and 
can form GVs with etched-track filter system (Pedrigi et al. 2011). To our surprise, 
HUVECs in the microfluidic device used in this study did not form a strong diffusive 
barrier nor GVs under flow condition. A closer examination showed that while HUVECs 
formed cell-cell junctions on the coverslips, there were numerous gaps in the monolayer 
on the softer collagen gel substrate while the monolayer appeared intact on the PDMS 
strips. This observation is likely due to HUVECs have tendency to migrate and assemble 
into networks on soft substrate (collagen gel) and remains confluent monolayer on stiff 
substrates (e.g. PDMS, glass, filters) (Saunders and Hammer 2010). In a previous study, 
Zervantonakis and colleagues (2012) showed that HUVECs could form intact monolayer 
on collagen gel in the microfluidic system with PDMS posts. We believe that it is likely 
due to cells’ ability to sense underlying substrate from some distance away and prevent 
networks formation since only half of HUVECs were sitting on top of the soft gel and the 
remaining cells were sitting on top of the PDMS posts. This result correspond to our 
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observation with SCECs, suggested that a strong diffusive barrier and an intact 
monolayer is required for cells to experience pressure gradients and form GVs. Further 
supporting our theory is the observation by Pedrigi et al. that HUVECs and SCECs in 
their in vitro system were able to form GV because etched-track filters could isolate the 
flow channel and prevent flow directed to adjacent gaps with lower resistance.  
In our microfluidic device, we also observed previously unidentified SCECs 
characteristics, including ECM digestion and cell migration, which can also affect the 
integrity of the cell monolayer. To confirm that MMP played the role in ECM digestion 
and cell migration, we treated SCECs with GM6001, a broadband MMP inhibitor. We 
found that GM6001 indeed significantly reduced collagen gel digestion and SCECs 
migration. Although the SCEC monolayer integrity appeared to be better with the 
GM6001, there were still gaps observed and GV were still unable to form under the 
pressure gradient. In addition, there is the possibility that juxtacanalicular tissue cells 
contaminated batches of SCECs during isolation from donor tissues, which are more 
fibroblasts cell-like and there are currently no cell biomarkers that can separate the 
juxtacanalicular tissue cells from SCECs. Lastly, our results have shown that Y27632 
significantly reduced F-actin in the cell cortex of SCECs, and thereby increase the 
likelihood of GV formation. Therefore, if SCECs can be manipulated and cultured in 
such conditions that allow them to express cell-cell junctions with strong diffusive 
barrier, then our system can be utilize to study their functional relevance as the final 
barrier to aqueous outflow resistance in the trabecular meshwork. 
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Figure 4.1: Microfluidic device design 
The present microfluidic design is based from previous work from Vickerman et al. and 
Zervantonakis et al. (Vickerman et al. 2008, Zervantonakis et al. 2012) with 
modifications. The design incorporates dual PDMS posts of half the channel width, 
which allows for continuous hydrogel region throughout the microfluidic device, thereby 
creating the “post-less hydrogel cage device.” (Left): The device has three channels with 
middle scaffold region separate the two media channels. (Right): In this study, cells were 
seeded in one of the media channel and the cells on top of scaffold (black circle) were 
subjected to basal-to-apical pressure gradient driven flow. 
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Figure 4.2: Fluorescent images of the endothelial monolayer and gel scaffold for 
diffusive permeability calculation 
Permeability was measured from quantifying the average intensity of the endothelial-
lined channel and gel scaffold (red rectangles) at the initial and final time point. 
Permeability coefficients PD were calculated based from previous published methods 
(Jeon 2014, Price 2008, Huxley 1987) and modified into the following equation: 
𝑃! =  !!!!!!!""#$!!!!!"# ∙  !!!!"#!!!!!"#∆! ∙ 0.2𝑐𝑚, where !!!!!!!""#$!!!!!"# is the initial step 
increase in fluorescence intensity, !!!!"#!!!!!"#∆!  is the initial rate of increase in 
fluorescence intensity as dextran diffuse into the gel scaffold, and the value of 0.2 cm is 
specific to this microfluidic system and determine from V/S, where V is the volume of 
the endothelial-lined microfluidic channel and S is the surface area of the endothelial 
monolayer. 
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Figure 4.3: Morphology of the (A) human lymphatic microvascular endothelial cells 
(LMECs), human Schlemm’s canal endothelial cells (SCECs), and human umbilical 
vascular endothelial cells (HUVECs); (B) SCECs form multicellular layers on 
collagen scaffold 
(A): LMECs and HUVECs appeared cobblestone-like while SCECs appeared spindle-
shaped. Additionally, LMECs and HUVECs were much smaller in dimension compared 
to the SCECs.  
(B): At higher density, it is apparent that SCECs appeared to lack contact inhibition and 
form cable-like multicellular layer structure on collagen scaffold. SCECs also appeared to 
digest underlying ECM and migrate into the scaffold. 
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Figure 4.4: Changes in 10kDa dextran diffusion of LMEC monolayer after Y27632 
treatment 
A: LMECs showed strong diffusive barrier before and after Y27632 treatment. Scaffold 
only devices showed no barrier present for the dextran. 
B: LMECs exhibited significantly higher diffusive permeability (Pd ) to the passage of 
10kDa dextran after Y27632 treatment (7.72x10-7±1.28x10-7 vs. 2.22x10-6±3.59x10-7 
cm/s, n=6 devices, P < 0.01) 
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Figure 4.5: 10kDa dextran diffusion in SCECs and HUVECs 
Neither SCECs nor HUVECs had established acceptable barrier against 10kDa dextran in 
the control groups, and the barrier appeared similar to scaffold only devices. 
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Figure 4.6: Hydraulic Permeability of LMECs 
There was no significant difference in hydraulic conductivity between Y27632-treated 
and untreated LMECs devices (0.79±0.11, n=8 vs. 1.18±0.19, n=10 μL/mmHg/min/cm2, 
P = 0.1). 
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Figure 4.7: F-actin visualization and giant vacuoles quantification in LMECs 
A: LMECs formed cell-cell junctions showed by positive F-actin staining along the 
periphery of the cells and Y27632 treatment resulted in significantly decrease in F-actin 
staining intensity and F-actin fibers along the cell periphery. Under basal-to-apical flow, 
LMECs showed formation of GVs (arrows) that exhibited dome-like elliptical cavity with 
the classic “signet ring” appearance in both control and Y27632 groups.  
B: GV number increased significantly in Y27632 treated group compared to controls 
(11±2 vs. 3±1, n=5 each, P < 0.01).   
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Figure 4.8: 3D Reconstruction of GV/cell-matrix separation in LMECs 
Using 3D reconstruction, we observed that in some cases, multiple LMECs appeared to 
lift up in a jointly manner similar to cell-matrix separation. Basal and apical pores (blue 
arrows) can be observed here. 
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Figure 4.9: F-actin visualization in SCECs 
SCECs did not exhibit cell-cell junctions and numerous gaps were observed both on the 
coverslips as well as on the collagen gel in both control and Y27632 treated groups. The 
control SCECs have intense F-actin staining in the cell periphery while Y27632 treatment 
reduced the overall F-actin staining as well as cell cortex F-actin. Additionally, SCECs 
appeared more star-shaped with Y27632 treatment compared to ellipsoid shape in the 
control group. Lastly, some SCECs appeared more round up with Y27632 treatment and 
GV were not observed in either control or Y27632 treated cells. 
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Figure 4.10: F-actin visualization in HUVECs 
For HUVECs, cell-cell junctions were observed on the coverslips, although gaps were 
still seen between some cells as well. On the collagen gel, however, HUVECs did not 
appear to form a continuous monolayer, as numerous gaps were seen. Interestingly, the 
HUVECs monolayer appeared more intact with cells on the PDMS strips. GV were not 
observed in either control or Y27632 groups. 
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Figure 4.11: SCECs can digest and migrate into collagen gel while LMECs and 
HUVECs do not 
SCECs were observed to digest their underlying ECM and migrated into collagen gel in 
as early as 2 days. In contrast, LMECs and HUVECs did not appear to digest their 
underlying collagen scaffold nor migrate into the gel for the duration of experiments. Red 
arrows: The plane where collagen scaffolds that appeared intact. Red brackets: Width of 
receding collagen scaffold.   
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Figure 4.12: MMP inhibitor GM6001 significantly reduced SCECs matrix digestion 
and cell migration 
Compared to the control, both 20uM and 50uM of GM6001 groups significantly reduced 
the ECM digestion and prevented majority of SCECs from migrating into the collagen 
gel. 
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CHAPTER 5 - ENDOTHELIAL GLYCOCALYX LAYER IN THE AQUEOUS 
OUTFLOW PATHWAY OF HUMAN AND BOVINE EYES 
 
Data presented in this chapter were accepted for publication in: 
Experimental Eye Research 128 (2014) 27-33. 
The final publication is available at http://www.journals.elsevier.com/experimental-eye-
research. 
Authors: Chen-Yuan Charlie Yang, Tiffany Huynh, Mark Johnson, Haiyan Gong 
 
 
Introduction 
Alcian blue, a copper-containing phthalocyanine, is a polyvalent basic dye that, 
when used in the fixative at physiological pH, can bind to glycocalyx (extracellular 
glycoproteins and glycosaminoglycans) forming insoluble precipitates to preserve the 
labile glycocalyx during dehydration and embedding processes (Hayat 1993). The goal of 
this study is to characterize the morphological structure of the glycocalyx in the aqueous 
outflow pathway. We preserved the glycocalyx layer using Alcian Blue 8GX, and then 
examined its thickness and distribution in the aqueous outflow pathway of both bovine 
and human eyes. We found this layer to be irregular in both the bovine and human 
outflow pathways with significant differences between the two species. 
 
Materials and Methods 
Enucleated bovine eyes (N=4) were obtained from a local abattoir and delivered 
on ice within 6 hours post-mortem. Enucleated human eyes (N=4) from anonymous 
donors without any known history of ocular diseases were obtained from National 
Disease Research Interchange (Philadelphia, PA) within 24 hours post-mortem. The 
bovine eyes were either perfusion-fixed (N=2) or immersion-fixed (N=2), while the 
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human eyes were perfusion-fixed. Perfusion-fixed eyes were perfused at 15 mmHg with 
Dulbecco’s phosphate-buffered saline (DPBS) with 5.5 mM of D-glucose for at least 30 
minutes at 34°C, the anterior chambers exchanged with 1% glutaraldehyde and 4% 
paraformaldehyde in DPBS containing 30 mmol/L MgCl2 and 0.05% (w/v) Alcian Blue 
8GX, and then perfused with the same solution for an additional hour. The eye was then 
hemisected and immersion-fixed in the same solution overnight. Immersion-fixed eyes 
were dissected to remove the lens and vitreous humor before immersing in the same 
fixation solution as perfusion-fixed eyes for at least 12 hours. All eyes were dissected 
into small tissue wedges and post-fixed in 1% aqueous osmium tetroxide and 1% 
lanthanum nitrate hexahydrate for 2 hours at room temperature, followed by en-bloc 
staining with uranyl acetate, dehydration in ascending series of ethanol, then replaced 
with propylene oxide and finally embedded in 100% Epon-Araldite. Ultra-thin sections 
(85 nm) of the trabecular outflow pathway were cut and examined with a transmission 
electron microscope (JOEL JEM-1011, Tokyo, JAPAN). 
Electron micrographs [bovine: ≥ 12 images/eye; human: ≥ 18 images/eye] were 
taken randomly at different regions (trabecular meshwork: TM; Schlemm's canal: SC; 
aqueous plexus: AP; collector channels: CC) of the aqueous outflow pathway and pooled 
for each region from all eyes to calculate the percent distribution and thickness of the 
glycocalyx. Percent distribution of glycocalyx on the endothelial surface (length of 
glycocalyx covering endothelial surface / total length of endothelial surface) was 
determined by the intensity plot profile of glycocalyx close to and parallel to the luminal 
membrane to include all the observable glycocalyx (including collapsed glycocalyx) 
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using ImageJ (NIH) (bovine: ≥16 measurements/region; human: ≥48 
measurements/region). A preset intensity was applied across all images to separate the 
glycocalyx from the background. In those regions where the glycocalyx was seen, its 
thickness was measured at randomly chosen regions of the TM, in the AP/SC, and CCs. 
Episcleral veins were used as positive controls. The results given in box-plots represent 
the 25th and 75th percentile, while the center line represents the median, with whiskers 
extending to a maximum of 1.5 interquartile range. The statistical analysis was done 
using R version 3.0.2 (R Foundation for Statistical Computing, Vienna, Austria.). 
Because the datasets were not normally distributed as determined using the Shapiro-Wilk 
test, the Mann-Whitney U nonparametric test was used to assess the statistical 
significance of difference seen in the distribution and thickness of glycocalyx in different 
regions. 
 
Results 
The glycocalyx, which appears as a layer of hair-like brushes similar to the 
endothelial glycocalyx reported previously (van den Berg, Vink, and Spaan 2003) (Figure 
5.1), validated our modified Alcian Blue staining method adapted for the aqueous 
outflow pathway. Figure 5.2 showed our positive controls, the glycocalyx in the 
episcleral veins of the bovine and human aqueous outflow pathways. We did not find any 
significant differences in the glycocalyx distribution in different regions of the outflow 
pathway when comparing immersion- and perfusion-fixed bovine eyes (glycocalyx 
distribution between immersion vs. perfusion: AP: 3-20 % vs. 3-65% p=0.49; TM: 21-43 
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% vs. 28-43 %, p=0.52, respectively), and thus, for bovine eyes, immersion- and 
perfusion-fixed data were pooled for the analysis. 
 The distribution of the glycocalyx was non-uniform in both the bovine (Figure 
5.3A-C) and human (Figure 5.3D-F) aqueous outflow pathways. In both species, the 
glycocalyx was most uniform in the CCs (Figure 5.3A, D). The distribution of glycocalyx 
was more variable in the proximal aspects of the outflow pathway, but differed somewhat 
between the two species. In the bovine eyes, the glycocalyx distribution was most 
variable on the wall of the AP, with some regions showing little or no coverage (Figure 
5.3B); the TM showed somewhat more uniform coverage than the AP but was less 
uniform than that seen in the CCs (Figure 5.3C). The human eyes showed a different 
pattern, with the most variable coverage in the TM, and a somewhat more uniform 
coverage of SC (Figure 5.3E, F). 
Quantitative studies confirmed these differences in glycocalyx distribution 
between the two species. In both bovine and human eyes, the surface coverage by 
glycocalyx was most complete in the CC (bovine: 37-76 %, n=23 images; human: 57-81 
%, n=52 images); this was followed in the bovine by the TM at 27-43 % (n=16), and then 
AP at 3-27 % (n=26) (p < 0.01) (Figure 5.4A); in the human, this order was reversed with 
the coverage in SC at 47-76 % (n=110) and the TM at 13-36 % (n=49) (p < 0.01) (Figure 
5.4B).  In bovine eyes, the thickness of the glycocalyx was very uniform in those regions 
where it was found: AP (70-122 nm, n=158: 25th to 75th percentiles), TM (68-124 nm, 
n=199), and CC (80-114 nm, n=404) (p > 0.05) (Figure 5.5A). In human eyes, the 
glycocalyx was thickest in the CC (109-166 nm, n= 521) followed by SC (88-154 nm, 
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n=1043), and then the TM (52-88 nm, n=288) (p < 0.001) (Figure 5.5B).  
 Ultrastructural observations revealed that the glycocalyx covered the plasma 
membranes of the TM, SC/AP, and CC endothelial cells (Figure 5.3). Alcian Blue stained 
the glycocalyx coated on the luminal surfaces of the SC/AP, while very sparse coating 
was seen on the basal surfaces of the endothelial cells of SC/AP.  Additionally, the 
plasma membranes of some juxtacanalicular tissue (JCT) cells also showed sparse 
distribution of glycocalyx in both human and bovine eyes (Figure 5.6). Also very 
noteworthy was the Alcian Blue staining pattern associated with the giant vacuoles (GVs) 
of the endothelium of SC. In both bovine and human eyes, glycocalyx was usually seen 
only coating the outer membrane and not inner membrane of the GVs of the AP (Figure 
5.7A, B) or SC (Figure 5.7C, D) whether the sections were passing through a basal 
opening or not. No Alcian Blue staining was found filling the lumens of either GVs or 
SC/AP, consistent with their being empty spaces. Lastly, glycocalyx distributions 
appeared similar on the outer surfaces of GVs in SC/AP as compared to the surrounding 
endothelium. 
 A most interesting finding in our study was that most transcellular pores passing 
through the endothelium of SC/AP were filled with glycocalyx, including both GV 
associated and non-GV associated pores (Figure 5.8). This was true for 10 of the 12 pores 
seen in human eyes and 8 of 9 pores seen in bovine eyes. Interestingly, in those GVs with 
a visible pore, particularly those in which a basal opening to the GV was also apparent, 
glycocalyx was found not only coating the outer membrane of the GVs but also sparsely 
coating the inner membrane of the GVs closest to the basal opening and closest to the 
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pore (Figure 5.8B,C). Glycocalyx was also seen in the extracellular matrix nearest the 
basal openings of the pore-associated GVs (Figure 5.8B,C). 
 
Discussion 
In this study, we applied the modified Alcian blue protocol published by van den 
Berg and colleagues to better preserve the labile glycocalyx (van den Berg, Vink, and 
Spaan 2003). While it is possible that the Alcian blue did not assess all aspects of the 
outflow pathway (and thus absence of staining does not necessarily imply absence of 
glycocalyx), our study has attempted to minimize that possibility by cutting tissue into 
small segments prior to Alcian blue-fixative immersion overnight. 
 We found that the glycocalyx in the aqueous outflow pathway was less thick than 
that reported for vascular endothelium and also less uniform. The thickness of the 
glycocalyx, in regions where it was found, ranged from 68 to 122 nm in the bovine 
outflow pathway and 52 to 166 nm in the human (25th to 75th percentiles). This is less than 
the range reported for vascular glycocalyx (200-500 nm), measured using comparable 
methods (Tarbell and Ebong 2010). 
  Glycocalyx is reported to be uniformly distributed in rat and mouse aortas but not 
in the microvessels, with perhaps half either not covered, or covered with a much thinner 
glycocalyx (Yen et al. 2012). Some arterioles have been reported to be without 
glycocalyx. These findings are, in general, consistent with our findings in the episceral 
veins, CCs and SC; however, in the TM of human eyes and in the AP of bovine eyes, 
glycocalyx was found to be even more sparse and variable than in most other 
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microvessels. The variability in the distribution of the glycocalyx in the outflow pathway 
that we found may relate to non-uniform flow of aqueous humor through these tissues 
(Overby, Stamer, and Johnson 2009, Keller et al. 2011, Battista et al. 2008). This non-
uniform flow in the aqueous outflow pathways results in heterogeneously distributed 
shear forces similar to variable glycocalyx distribution in the vascular system resulting 
from heterogeneous blood flow distribution (van den Berg, Vink, and Spaan 2003, van 
den Berg, Spaan, and Vink 2009). 
 The finding of a glycocalyx in SC/AP allows for speculation as to its role as a 
possible regulator of aqueous outflow resistance, and thereby, IOP. Changes in shear 
stress levels in SC/AP would be expected to be transduced by the glycocalyx and 
modulate NO release (Tarbell and Ebong 2010). In SC/AP, this autocrine response would 
then be expected to relax these cells, a response that has been associated with decreased 
outflow resistance (Zhou et al. 2012). Thus, for example, if IOP were to increase, this 
would cause narrowing of SC/AP (Johnstone and Grant 1973, Van Buskirk 1982, Battista 
et al. 2008, Zhang et al. 2009), thus increasing the shear stress level in SC/AP (shear 
stress is inversely proportional to the size of SC/AP), and thereby initiating this 
regulatory response to lower the IOP. 
 Overall, our observation of glycocalyx staining pattern in the aqueous outflow 
pathway delineated by Alcian Blue appeared similar to previous observation using 
cationic ferritin (de Kater, Melamed, and Epstein 1989, Ethier and Chan 2001, Tripathi, 
Tripathi, and Spaeth 1987), ruthenium red(Richardson 1982, Grierson, Lee, and Abraham 
1977), and colloidal iron (Grierson and Lee 1975, Armaly and Wang 1975, Tripathi, 
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Tripathi, and Spaeth 1987) but with much better ultrastructure. The outer membrane of 
giant vacuoles had significantly more continuous glycocalyx coverage compared to that 
of the inner membrane, which is likely due to the differences in the sialic acid residues 
between the luminal and basal lining of giant vacuoles (Tripathi, Tripathi, and Spaeth 
1987). Furthermore, we found that most inner wall pores were filled with glycocalyx. 
Although a previous study had observed the accumulation of cationic ferritin at possible 
pore locations, that study used the scanning electron microscope with which the authors 
were only able to identify the surface but not inside of the pores (Ethier and Chan 2001). 
Since the inner wall pores are thought to be passages for aqueous humor to enter SC 
(Johnson 2006), glycocalyx filling the pores may play a role in regulating aqueous 
outflow resistance.  
 Weinbaum et al. (Weinbaum et al. 2003) estimated the specific hydraulic 
conductivity of glycocalyx to be 3.2 nm2. Using Darcy's law, we can estimate the flow 
resistance of a glycocalyx-filled pore of diameter 1 µm and thickness 0.1 µm and 
compare this to the resistance of empty pore of the same dimensions. We found that a 
glycocalyx-filled pore has potentially a far higher flow resistance than an empty pore, 
confirming that the glycocalyx filling the pores could potentially play a role in regulating 
aqueous outflow resistance1. If so, the bulk of aqueous flow might pass through pores that 
are not filled with glycocalyx. However, Ethier and Chan showed that removal of sialic 																																																								1	For a glycocalyx-filled pore, Darcy's law gives a flow resistance of µL/(KA) with 
aqueous humor viscosity µ, pore length L, permeability of the glycocalyx K, and A=πR2 
with pore radius R; for an empty pore, Sampson's law give a resistance of 3µ/R3 and thus 
the ratio of these two resistances is LR/(3πK). With K=3.2 nm2 (Weinbaum et al. 2003), 
assuming L= 200 nm (a typical thickness of the wall of a giant vacuole), this ratio is 3300 
for a 1 µm diameter pore.	
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acid (a component of glycocalyx) with neuraminidase does not alter aqueous outflow 
resistance (Ethier and Chan 2001). Further studies are warranted to understand the role of 
glycocalyx in the aqueous outflow pathway. 
In summary, this study has demonstrated the detailed structure and distribution of 
the glycocalyx in both bovine and human aqueous outflow pathways, which is species-
dependent. The implications of a non-uniform glycocalyx in the aqueous outflow 
pathway remain to be clarified. More importantly, based on our findings that showed the 
glycocalyx lines the wall of SC and fills most of the pores entering SC and findings from 
vascular endothelium, it is likely that the glycocalyx in SC plays a role in transduction of 
shear stress and perhaps regulation of outflow resistance. 
 
 
 
 
 
 
 
 
 
 
 
  
131	
Figure 5.1: Endothelial glycocalyx layer (glycocalyx) in bovine and human aqueous 
outflow pathways 
Glycocalyx appears as a layer of hair-like structures in bovine collector channel (A) and 
human Schlemm’s canal (B) of the aqueous outflow pathway. 
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Figure 5.2: Glycocalyx in the bovine and human episceral veins 
Epithelial veins (EPV) served as a control. The glycocalyx was relatively uniform in both 
bovine (A) and human (B) episceral veins.  
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Figure 5.3: Glycocalyx in the bovine and human aqueous outflow pathways 
A, D: In the bovine and human collector channels (CC), the glycocalyx (black arrows) 
was relatively uniform. B, E: In the bovine aqueous plexus (AP), the glycocalyx (black 
arrows) was variable and less uniform than that in the CC, with some regions showing 
little or no glycocalyx (arrowheads); in human Schlemm’s canal (SC), the glycocalyx 
was relatively uniform but less so than in the CC with some regions showing little or no 
glycocalyx (arrowheads). C, F: On the bovine trabecular beams, the glycocalyx (black 
arrows) was also less uniform than that in the CC with some regions showing little or no 
glycocalyx (arrowhead); on the human trabecular beams, the glycocalyx was less uniform 
than that in the CC and SC with some regions showing little or no glycocalyx 
(arrowheads). ITS: Intertrabecular space. 
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Figure 5.4: Glycocalyx distribution 
In bovine eyes (A), the ordering of decreasing percentage of the endothelial surface 
covered by glycocalyx was CC > TM > AP (p < 0.01). In humans, more uniform 
glycocalyx was seen in SC than in AP of bovines. This ordering was different: CC > SC 
> TM (p < 0.01) 
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Figure 5.5: Glycocalyx thickness 
In bovine eyes, the glycocalyx thickness was not significantly different on the surfaces of 
the AP, TM, or CC (p > 0.05), whereas in human eyes, the thickness in these three areas 
was different (CC > SC > TM, p < 0.001). 
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Figure 5.6: Glycocalyx in the juxtacanalicular tissue (JCT) region 
Glycocalyx was found sparsely distributed on the plasma membranes of some JCT cells 
in both bovine (A) and human (B) eyes, which was much less than the respective 
endothelial cells of aqueous plexus (AP)/ Schlemm’s canal (SC) in the same image.  
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Figure 5.7: Glycocalyx on the giant vacuoles 
In bovine eyes, glycocalyx only sparsely coated the outer membrane, not the inner 
membrane of a giant vacuole (GV) of aqueous plexus (AP) endothelium whether a basal 
opening was not present (A) or present (B, arrowhead). The same is true in human eyes; 
glycocalyx is usually seen only coating the outer membrane but not inner membrane of a 
GV of Schlemm’s canal (SC) endothelium whether a basal opening is not observed (C) or 
is observed (arrowhead, D). More uniform glycocalyx was seen on the outer membrane 
of GVs in human eyes than in bovine eyes. 
144	
 
  
145	
Figure 5.8: Glycocalyx in the pores 
A: A pore in a GV (arrow, insert) of a human eye is filled with glycocalyx, which also 
coats the outer membrane, but not the inner membrane of the GV; note the membranous 
material apparently in the passage through the GV. B: Glycocalyx is seen filling a pore 
(arrow, inset) in a GV, coating the outer membrane, and sparsely coating the inner 
membrane of the GV close to the basal opening and the pore, as well as the extracellular 
matrix near the basal opening (arrowhead) of the GV in a bovine eye. C: Glycocalyx was 
seen within a pore of a giant vacuole (arrow), and coating the outer surface and left side 
of the inner membrane of the giant vacuole, which is close to a basal opening (*), but not 
the right side of the inner membrane of the giant vacuole (arrowheads) in a human eye. 
D: Glycocalyx was seen filling a pore not associated with the giant vacuole (arrow). 
Insets show the pore filling with glycocalyx at a higher magnification. Significant Alcian 
Blue staining was also seen in the basal side of extracellular matrix (*). 
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CHAPTER 6 - GENERAL CONCLUSIONS 
Summary 
The goal of this dissertation is to further our understanding of the role that the 
inner wall of SC endothelium, juxtacanalicular tissue, and trabecular beams has in 
regulating outflow resistance. The studies performed in this thesis were (i) to determine 
the effects of Y27632 on aqueous humor outflow dynamics and associated morphological 
changes in human eyes and in (ii) laser-induced hypertensive monkey eyes, (iii) to 
develop a three-dimensional microfluidic system to study the function of SC endothelial 
cells, and (iv) to characterize the endothelial glycocalyx layer in the trabecular outflow 
pathway. 
Previous studies have suggested that the majority of the outflow resistance resides 
in the proximal region of the inner wall of the SC, namely the inner wall SC endothelium 
and its underlying juxtacanalicular tissue. However, conflicting experimental and 
theoretical findings in both normal and glaucomatous eyes prevent consensus among 
researchers and make this an active area of research. Furthermore, a new class of 
glaucoma medication, Rho-kinase inhibitors which targets cells of the trabecular outflow 
pathway, is currently undergoing clinical trials and has shown to be effective in lowering 
IOP. How the Rho-kinase inhibitors lower the IOP through decreasing outflow resistance 
remains unclear. Through the use of Y27632, an easily accessible Rho-kinase inhibitor, 
we were able to determine the association between the changes in aqueous outflow 
resistance and structural and functional changes in the trabecular outflow pathway. 
Moreover, we validated a novel three-dimensional microfluidic system to study the effect 
148	
of Y27632 on the resistance barrier and structural changes in monolayer of endothelium 
cells. Lastly, we investigated the endothelial cell surface glycocalyx, an area of research 
that is underexplored to better understand its potential role on aqueous outflow resistance. 
Together, the results have provided a better understanding of the role of the inner wall 
endothelium of SC, juxtacanalicular tissue, and trabecular beams in regulating the 
outflow resistance. 
Our proposed model for studies that look at the overall inner wall region of SC is 
through the use of ex vivo ocular perfusion in combination with fluorescent microspheres 
in enucleated normal human (chapter 2) and laser-induced hypertensive monkey eyes 
(chapter 3). The ex vivo ocular perfusion system provides a useful tool to do a short-term 
study (less than a day) in the enucleated eyes with drug treatment and measure the 
changes in outflow facility before and after drug treatment and associated changes in 
aqueous outflow pattern and morphology that may responsible for the change in outflow 
facility. Our study in normal human eye model was a continuation from our previous 
non-human animal eyes where Y27632 was shown to increase the available area of 
aqueous outflow as determined by EFL. However, the anatomical differences in non-
human eyes resulted in a washout effect (i.e. perfusion volume-dependent increase in 
outflow facility). Moreover, separation between the inner wall endothelium of SC and 
JCT observed in non-human eyes do not occur in human eyes. Therefore, our study in 
chapter 2 provides a useful direct comparison with normal non-human eyes as well as the 
effects of Y27632 treatment on the trabecular outflow pathway. Our results demonstrated 
the effectiveness of 3 hours of Y27632 treatment in increasing aqueous outflow, which is 
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associated with increase in the area of aqueous outflow (EFL) and JCT thickness. 
Next, we applied the same tool to study the effects of Y27632 using the laser-
induced ocular hypertensive model. Experimental induced ocular hypertensive monkey 
model provides the best alternative non-human glaucoma model because of scarcity of 
glaucoma eyes, aging eyes, prior treatment for other diseases, and different 
histopathological stages. As result, they would have significant variation in response to 
drug treatments. Laser-induced ocular hypertensive monkey model potentially 
circumvents these problems from affecting the quality of the results. However, as shown 
in our studies in chapter 3, there were still individuals IOP variations and different IOP 
elevation as the result of laser treatment. Factoring the limitations and advantage of our 
perfusion methods, our data showed that both Y27632-treated and untreated normal eyes 
had significant increased outflow facility while Y27632-treated hypertensive eyes had a 
slight but insignificant increase in outflow facility compared to controls. This suggests 
that a longer treatment of Y27632 is likely needed to see an increase in outflow facility. 
Additionally, the decreased available TM area in hypertensive eyes greatly reduced the 
washout effect. Furthermore, while EFL was increased in normal and non-lasered regions 
of hypertensive eyes with and without Y27632, there were no significant differences 
between these groups, which are likely due to a small sample size, the length of treatment 
time, sensitivity of EFL measurement, and lack of significant differences in change in 
outflow facility. Morphologically, the majority of the trabecular outflow pathway in 
hypertensive eyes becomes “non-functional” from laser-burned, including collapse SC, 
compact TM, dense ECM, and TM and inner wall cell loss. Our studies suggested that 
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Y27632 may be less effective in advanced stage glaucoma patients if there was 
significant cell loss in the trabecular outflow pathway; however, ex vivo ocular perfusion 
system lacks the ability to study uveoscleral outflow and the episcleral venous pressure, 
which could be additional mechanisms for the Rho-kinase inhibitors to lower IOP. 
After investigating the effect of Y27632 on the outflow facility, outflow 
hydrodynamics and morphology in the trabecular meshwork, we turned to our focus on 
the resistance barrier generated by the inner wall endothelium of SC (chapter 4). To 
mimic the in vivo microenvironment of the inner wall endothelium of SC, we validated a 
novel three-dimensional microfluidic system to study the resistance barrier and giant 
vacuole formation using lymphatic microvascular endothelial cells in vitro and some 
preliminary data with primary human SC endothelial cells and human umbilical vascular 
endothelial cells. The lymphatic microvascular endothelial cells are good model cells 
which have similar biomarkers (including Prox-1) and experience similar biomechanical 
environment (basal-to-apical stress) as the endothelial cells of SC. Our results supported 
our hypothesis that decreased in actin cytoskeleton by Y27632 resulted in lowering the 
cell stiffness, which allowed the cells to easily deform under stress and allowed GV to 
form. Indirectly, we demonstrated that our microfluidic system is capable of studying the 
Y27632 effects on cell cytoskeleton and giant vacuole formation under basal to apical 
flow in any given cell lines if the cells form a nice monolayer with a barrier function. 
This system can be used to study the SC endothelial cell dynamics and aqueous humor 
transport mechanism in the future.  
In the final section of this thesis, we investigated glycocalyx expression on 
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endothelial cells in the trabecular outflow pathway. Studies into glycocalyx expression on 
endothelial cells is often grouped together with other glycosaminoglycan studies, which 
filled the “empty space” of the trabecular outflow pathway. In addition, there are 
conflicting results making it unsure if glycocalyx expression had any relevance in 
outflow resistance. In this study, we focused on just the cell surface glycocalyx using 
Alcian blue, a poly-cationic dye, to preserve the ultrastructure of the endothelial 
glycocalyx. This allowed us to quantify the height and distribution of the glycocalyx. 
Most importantly, for the first time, we found that glycocalyx was expressed filling the 
drainage pores of the endothelial cells of SC, suggesting an important role for the 
glycocalyx in regulating flow through the pore, and the outflow resistance. If further 
experimental evidence supports the expression of glycocalyx filled SC endothelial pores 
in regulating fluid flow, it will fundamentally change the theoretical models used for 
determine the aqueous humor outflow resistance. 
 
Future Direction 
Based from our success with the lymphatic microvascular endothelial cells and 
our preliminary data from the primary SC endothelial cells, we have shown that the 
microfluidic model will work if cell lines can exhibit a strong barrier function. 
Specifically, the SC endothelial cells used in our study not only have numerous gaps as a 
monolayer, but they also lacked cell-cell junctions. Additionally, these SC endothelial 
cells exhibited fibroblast-like behavior. They preferentially migrate into the underlying 
extracellular matrix, further worsening the integrity of the monolayer. There are 
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potentially two solutions to address this issue. First, it is worthwhile to optimize the SC 
endothelial cell culture conditions. The SC endothelial cells appeared to transform and 
lose their distinctive biomarkers within few days of isolation from SC of mouse eyes 
(Choi and Park 2016, unpublished data). This suggests that a preservation of the proper 
SC cell phenotype is possible given the right cell culture condition. Second, it would be 
important to obtain a different source of SC endothelial cells. Angular aqueous plexus 
cells from porcine eyes (equivalent of the SC endothelial cells in human eyes) have been 
successfully isolated (Lei et al., 2010) and expressed endothelial cell markers (such as 
vWF, VE-cadherin). Although morphologically, the aqueous plexus cells appeared 
different from the SC endothelial cells (cobblestone-like versus ellipsoid shape) and 
whether proper cell-cell junctions can be formed remain to be determine, the porcine 
aqueous plexus cells provide a potential fresh and abundant cell source as an alternative 
for studying the dynamics of SC cells in the microfluidic system.  
Since our study of the endothelial glycocalyx in the aqueous humor outflow 
pathway was only conducted in normal human eyes, the next logical extension is to study 
if there are any changes of the glycocalyx expression in glaucomatous eyes. Given the 
scarcity of the glaucomatous tissue and the different disease stages, it is likely there will 
be significant variation among different eyes. Previous studies by De Kater and 
colleagues (1989) show segmental differences in glaucomatous eyes with cationic 
ferritin. Therefore, we expect that it is likely that there will be segmental differences with 
the Alcian blue staining as well. Furthermore, given that we already have one normal and 
one laser-induced ocular hypertensive eye perfused with Alcian blue, we could 
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potentially perform a four-way comparison between normal human, normal monkey, 
glaucomatous human and laser-induced hypertensive monkey eyes. In addition to the 
studies outlined in chapter 5, it would be of interest to study the three-dimensional 
structure of the glycocalyx on cell surface and at the pore regions. Our lab has recently 
developed the technique to reconstruct the three-dimensional SC endothelial cells and 
their adjacent connections using block-face scanning electron microscopy (Lai et al., 
ARVO 2016). However, an adaptation of this technique will be required to study the 
glycocalyx due to the staining requirement differs for scanning and transmission electron 
microscopy.  
Lastly, we can next investigate the physiological relevance of the glycocalyx on 
outflow resistance by abolishing the glycocalyx using enzymatic treatment, including 
hyaluronidase, heparinase III, chondroitinase ABC. However, the trabecular outflow 
pathway is filled with GAGs in addition to cell surface glycocalyx, which will be 
removed as well using standard perfusion method. Therefore, retroperfusion technique 
will be needed to introduce the enzymes from the limbal vessels, through the collector 
channels, and into Schlemm’s canal (Ethier et al., 1993, Ethier et al., 1995). Thereafter, 
the standard perfusion technique can be applied. It was shown previously that 
retroperfusion with vehicle alone does not alter facility or change outflow pathway 
morphology. Thus, any changes in outflow facility and structural changes will be the 
result of glycocalyx removal from the endothelium of SC and collector channels only.  
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